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Abstract The lymph node sinus are channel structures of
unquestionable importance in immunology and pathology,
specifically in the filtering of the lymph, the transport and
processing of antigens, the adhesion and migration of immune
cells, and the spread of metastatic cancer cells. Our knowledge
of the cell and molecular biology of the sinus-forming cells is
still limited, and the origin and biological nature of these cells
have long been amatter of debate. Here, we review the relevant
literature and present our own experimental results, in
particular concerning molecular markers of intercellular
junctions and cell differentiation. We show that both the
monolayer cells lining the sinus walls and the intraluminal
virgultar cell meshwork are indeed different morphotypes of
the same basic endothelial cell character, as demonstrated by
the presence of a distinct spectrum of general and lymphatic
endothelial markers, and we therefore refer to these cells as
sinus endothelial/virgultar cells (SEVCs). These cells are
connected by unique adhering junctions, termed complexus
adhaerentes, characterized by the transmembrane glycopro-
tein VE-cadherin, combined with the desmosomal plaque
protein desmoplakin, several adherens junction plaque pro-
teins including α- and β-catenin and p120 catenin, and
components of the tight junction ensemble, specifically
claudin-5 and JAM-A, and the plaque protein ZO-1. We
show that complexus adhaerentes are involved in the tight
three-dimensional integration of the virgultar network of
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SEVC processes along extracellular guidance structures
composed of paracrystalline collagen bundle “stays”. Overall,
the SEVC system might be considered as a local and specific
modification of the general lymphatic vasculature system.
Finally, physiological and pathological alterations of the
SEVC system will be presented, and the possible value of
the molecular markers described in histological diagnoses of
autochthonous lymph node tumors will be discussed.
Keywords Sinus endothelial/virgultar cells (SEVCs) .
Desmoplakin . CD31 . Thrombomodulin . LYVE-1 .
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Introduction
Most of the vascular system of the mammalian body in which
fluid and cells are transported, including both blood and lymph
vessels, is composed of endothelium-lined tubes or channels of
widely variable caliber, which exhibit a free lumen. In some
parts, however, venous and lymphatic vessels occur from
which valvular structures project into the lumen thereby
contributing to the unidirectional flow. A unique exception to
the structural principle of the free lumen in the vasculature is
represented by the sinus1 of lymph nodes, i.e., the lymph
system leading from the afferent vessels via the subcapsular
(marginal) and the intermediate (cortical) sinus to the
medullary sinus and finally the efferent lymphatic vessels.
Light- and electron-microscopic studies have shown that the
sinus contain a relatively dense meshwork of cell processes
and extracellular fibers (for reviews, see for example, Aschoff
1924; Akazaki 1953; Raviola 1975; Sakuma et al. 1981;
Wacker 1994). Thus, the potentially interactive, reactive, and
binding surface of the total endothelial cell lining and of the
cells forming the luminal meshwork is greatly enhanced. As a
result, this meshwork reduces the flow speed of the
percolating lymph components considerably. Obviously, the
sinus with their outer lining and the intraluminal “virgultum”2
system are placed effectively for filtering and interacting
with other cells (in particular, for interactions with the
various antigen-presenting cells, lymphocytes, and macro-
phages) and with variously sized particles, complexes,
and free molecules (e.g., Drinker et al. 1933, 1934;
Forkert et al. 1977; for further references, see below).
Specifically, a series of recent reports has demonstrated
the importance of the sinus-lining cells and the luminal
meshwork, including the trabeculae-ensheathing cell layer,
for the sorting, transport, and processing of lymph
components (for recent references, see Gretz et al. 2000;
von Andrian and Mempel 2003; Prevo et al. 2004; Sixt et
al. 2005; Bajénoff et al. 2006). The lymph node sinus
system is also known to be of eminent importance in
various pathological processes, including immunological
diseases and, in particular, cancer cell metastasis. The
limited extent of the information concerning the cell and
molecular biology of the lymph node sinus system is
therefore surprising.
The nature of the surface-lining and of the luminal cells
of the lymph node sinus has been a matter of debate for a
long time. Whereas the sinus walls are covered by a layer
of flat endothelium-like cells, the intraluminal virgultum is
composed of partly stellate cells of dendritic morphology,
characterized by thin, often branched processes, some of
which are closely associated with fine “reticular fibers”
containing collagen bundles. In earlier studies (e. g.,
Akazaki 1953), the outer sinus lining cells were regarded
as an endothelium or reticulo-endothelium and the mesh-
work in the sinus lumina as reticulum cells. On the other
hand, Aschoff (1924) had previously suggested that they
were essentially two morphotypes of the same cell type
system of “reticulo-endothelial cells”, which, on the one
hand, lined the sinusal spaces and, on the other hand,
formed the intrasinusal meshwork, i.e., the virgultum. Other
authors have used the terms “reticular lining cells” and
“trabecular reticulum cells” for the sinus-lining cells and
the intrasinusal reticular cells, respectively, but have also
emphasized their ultrastructural and cell type relationship
(e.g., Farr et al. 1980). More recently, however, several
authors have argued against a relationship of the sinus-
lining cells and the luminal cells to vascular endothelial
cells and have denied their endothelial character (e.g.,
Wacker 1994; Wacker et al. 1997; for discussions of earlier
references see therein and, e.g., Forkert et al. 1977). In the
present article, molecular biological data from our group
and from several other laboratories are presented to
demonstrate that (1) sinus-wall-lining cells and intrasinusal
meshwork cells belong together essentially as two morpho-
types of the same cell type, and (2) both morphotypes
represent a distinct subform of a vascular endothelial cell
related to, but in certain aspects distinct from, the
endothelial cells of lymphatic vessels. For the sake of both
simplicity and clarity, we shall collectively refer to these
2 As the meaning of the Latin words “rete” and “reticulum” is
obviously restricted to one-layered two-dimensional “net” structures,
we here omit the use of the term “retothelium”, originally coined by
Roulet (1954) and meant to include diverse reticular cell types of the
lymphatic sinus and pulpa. Instead, we shall refer to the entirety of the
three-dimensional meshwork of cells and cell processes extending
throughout the sinus lumen as a “virgultum”, i.e., a space filled with
elongated structures resembling bushes and brush forming a thicket or
shrubbery of cells and cell projections, with many branches and
without a preferential order. Consequently, we refer to the endothelial
monolayer as “sinus-lining endothelium” and to the intraluminal three-
dimensional bushwork of endothelium-type cell structures as the
“virgultum”.
1 As this is a Latin word, we retain the correct plural form throughout
this article.
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cells as the “sinus endothelial/virgultar cell” (SEVC)
system.
In particular, we shall focus on a peculiar structural
feature common to the SEVCs and, partly, also to certain
other lymphatic endothelial cells, i.e., the specialized and
unique cell-cell junctions of the complexus adhaerens type.
In 1990, we noticed that variably sized, often extended cell-
cell junctional structures connected the SEVCs of the
lymph node sinus, not only in the sinus-lining cell layer,
but also in the virgultar cell meshwork in the lumina, and
that these were a type of adhering junctions sui generis,
both with respect to their morphology and their molecular
composition (Schmelz et al. 1990; Schmelz and Franke
1993). Not only the cells of the outer lining endothelial cell
layer, but also the intrasinusal SEVCs were interconnected
by complex adhering junctions characterized by a highly
complex and variable morphology and a characteristic VE-
cadherin-based junction molecular ensemble, anchored in
an α- and β-catenin-containing cytoplasmic plaque that
was conspicuously rich in desmoplakin, a protein known to
be a marker for epithelial desmosomes and the composite
junctions of cardiomyocytes (Franke et al. 1981, 1982,
1994, 2006; Schmelz and Franke 1993; Schmelz et al.
1994; Hämmerling et al. 2006; Borrmann et al. 2006).
Similar desmoplakin-positive adhering junctions have also
been identified in endothelial cells of certain lymphatic
vessels, and desmoplakin also appears to be important in
junctional assemblies of certain endothelia in embryogen-
esis (Gallicano et al. 2001; Zhou et al. 2004; for general
aspects, see also Valiron et al. 1996; Kowalczyk et al. 1998;
Cattelino et al. 2003; Dejana et al. 1999, 2000; Sleeman et
al. 2001; Stacker et al. 2002; Dejana 2004).
Desmoplakin has therefore been introduced as a further
special diagnostic marker for a certain part of the lymphatic
endothelial system (see, e.g., Ebata et al. 2001a, b), which
histochemically is practically defined as a type of vessel
positive both for desmoplakin and α- and β-catenin on the
one hand (Schmelz et al. 1994; Franke et al. 1994) and for
lymphatic markers such as LYVE-1 on the other (e.g.,
Banerji et al. 1999; for reviews, see also Stacker et al. 2002;
Al-Rawi et al. 2005). This novel and specific kind of
adhering junction in SEVCs and endothelia of lymphatic
vessels has been generally termed the complexus adhae-
rens, the “complex junction”. The molecular complexity
has subsequently turned out to be even greater, as certain
molecules of the tight junction ensemble such claudin-5 and
zonula occludens protein ZO-1 are also regularly demon-
strable within the morphological confinements of the
complexus adhaerentes (Hämmerling 2004; Hämmerling
et al. 2006; see also Baluk et al. 2007; Pfeiffer et al. 2008).
Thus, the emerging picture of the complexus adhaerens
seems to be that of an unusually complex combination of
junction molecules, combining members of adherens
junctions, such as the zonula adhaerens and desmosomes,
with those of tight junctions. Most recently, this unusually
complex composition has been confirmed and markedly
extended by Pfeiffer et al. (2008).
Because of this astonishingly high molecular complexity
and the general importance for our understanding of
molecular interactions and functions in cell-cell coupling,
and in view of the great importance of the SEVC system of
lymph nodes in immunology and in cancer cell metastatic
processes, we review here accumulated and newly added
information and also summarize data on SEVCs in certain
“reactive” and pathological states. We also discuss possible
special functions of SEVCs and the pathological impor-
tance of these molecular markers in lymph node pathology,
including the diagnosis of autochthonous tumors of lymph
nodes.
Materials and methods
Preparations of snap-frozen human lymph nodes have been
previously described (e.g., Schmelz et al. 1994; Hämmerling
2004; Hämmerling et al. 2006; Sievers 2009). Paraffin
blocks containing normal and pathologically altered human
lymph nodes were taken from the archival files of the
Institute of Pathology of the University of Marburg. These
samples had been obtained during surgery for diagnostic or
therapeutic reasons and had been routinely formaldehyde-
fixed immediately after removal and subsequently embed-
ded in paraffin. Some lymph nodes were obtained as fresh
tissue samples immediately snap-frozen in liquid nitrogen,
representing residual tissue after frozen tissue section
diagnosis. All human tissue samples were taken for the
study only after pathological diagnosis had been completed
and were used without knowledge of the personal data of
the patients. Fresh lymph node tissue samples of bovine
origin were obtained from the abattoir at Mannheim and
fixed as described (see, e.g., Schmelz and Franke 1993;
Hämmerling et al. 2006). The preparation of cryostat and
paraffin sections and further processing for immunolocal-
ization experiments were as previously reported, including
conventional immunofluorescence microscopy and confo-
cal laser-scanning microscopy (single- and double-label) of
cryostat sections and avidin-biotin-based immunohisto-
chemistry of sections of paraffin-embedded tissue samples
(Schmelz et al. 1994; Hämmerling et al. 2006; Sievers
2009). Tissue samples for conventional and immunolabel-
ing electron microscopy were fixed and processed as
previously described (Schmelz et al. 1994; Hämmerling
et al. 2006).
Primary antibodies used, their sources, and methodolog-
ical details, including antigen retrieval procedures for
paraffin sections, are listed in Supplementary Table 1 (see
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also Schmelz and Franke 1993; Schmelz et al. 1994;
Borrmann et al. 2006; Hämmerling et al. 2006; Moll et al.
2006; Wuchter et al. 2007). Micrographs of serial sections
were analyzed by using tomo- and topographical protocols
(Schmelz and Franke 1993).
Results and discussion
Lymph nodes are essential secondary immune organs that
are positioned at strategically important sites along the
lymphatic system in the body. Soluble antigens, complexes,
particles and immune and other cells enter the lymph nodes
with the lymph flow via the afferent lymphatic vessels from
the respective drainage area. Alternatively, cells may enter
lymph nodes by extravasation from postcapillary venules of
the blood stream. Whereas considerable information has
been accumulated with respect to the structure and
organization of the lymph node and its functions in the
initiation and coordination of the cellular immune response
(for a recent review, see Willard-Mack 2006), relatively
little is known about the surface-lining and intraluminal cell
structures of the lymph node sinus, the SEVC system.
This cellular system comprises two morphologically
different categories of cells: the cells lining the sinus
margins and the multiform, partly branched, “stellate” cells
forming a meshwork in the sinus lumen. The latter cover
the collagen fibril bundle “stays” (supports) of the sinus
lumen, forming irregular-appearing virgultar arrays. Both
forms of SEVCs are characterized by cytoplasmic projec-
tions, frequent cell-cell contacts, and variously sized
junctional complexes. The endothelial cell layer of the
sinus-lining cells and the three-dimensional virgultar
meshwork aspect of the intraluminal cells are also directly
visible in surface-scanning electron micrographs (see, e.g.,
Fujita et al. 1972; Raviola 1975; Farr et al. 1980; Ushiki et
al. 1995). On the other hand, this thicket-like cell
meshwork organization characterized by numerous cell
processes interconnected by variously sized junctions
obviously does not meet many researchers’ view of an
“endothelium”. Thus, several authors have concluded that
these cells, which are among the most frequent cell types in
the mature lymph node, are not of a vascular endothelial
nature or origin but represent special forms of non-
endothelial differentiation, probably of a monocytic type,
and should be regarded as “immune accessory cells”, i.e.,
cells of a three-dimensional system serving accessory
immunological functions (for reviews and controversial
discussions, see, e.g., Raviola 1975; Crivellato and Mallardi
1998; Wacker 1994; Wacker et al. 1997; Kaldjian et al.
2001; Willard-Mack 2006; see also below).
Indeed, we have learned with some surprise that two
different kinds of lymph node cells with three-dimensional
meshwork morphology, viz., the follicular dendritic reticu-
lum cells (FDCs) and the SEVCs, have some structural
aspects and molecules in common, such as the protein
desmoplakin, forming a junction-associated cytoplasmic
coat (Schmelz et al. 1990, 1994; Schmelz and Franke 1993;
Franke et al. 1994; Wacker 1994; Hämmerling et al. 2006),
which so far has only been reported for epithelial,
myocardial, and meningeal cells (e.g., Franke et al. 1982;
Kartenbeck et al. 1984; Moll et al. 1986; Akat et al. 2008).
The idea that the FDCs represent immune accessory cells
playing an important functional role in the humoral immune
response appears to be generally accepted (e.g., Tew et al.
1990, 2001). However, although the junctional protein
desmoplakin is common to both FDCs and SEVCs, the
underlying junctional structures and molecular ensembles
are very different (see below). Moreover, the SEVCs have
also recently been found to be positive, by immunostaining,
for an increasing number of endothelial marker molecules
including markers of lymphatic endothelial cells (Schmelz
and Franke 1993; Schmelz et al. 1994; Hämmerling et al.
2006; Pfeiffer et al. 2008; and data below).
Using a series of cell differentiation markers for
immunocytochemistry at the light- and electron-microscopical
level, we have therefore systematically characterized the
cytoskeletal and junctional proteins and glycoproteins of
the SEVC system of lymph nodes in mammals. In
particular, we have demonstrated not only the essentially
endothelial character of these cells, but also that they are
connected by adhering junctions that have a highly
complex morphology and a unique molecular composition,
and that therefore have been subsumed under the collective
name “complexus adhaerens” (Schmelz and Franke 1993).
Whereas some of these junctions, notably those of the
sinus-lining cells, i.e., endothelial cells sensu stricto, appear
predominantly as distinct puncta, fasciae, or zonulae of the
adherens junction type, we have mostly focused on the
complex, often extended, junctional structures connecting
cells of the virgultar meshwork of the SEVCs in the sinus
lumina, i.e., structural complexes that have not yet been
seen in any other cell type (this category of complex
formations has been termed “syndesmos”; Schmelz and
Franke 1993). Both the sinus-lining endothelial and intra-
luminal virgultar cells are characterized by the general
presence of highly specialized junctions of the complexus
adhaerens type. Moreover, they exhibit essentially identical
differentiation marker profiles (see below). Thus, in cell
biological terms, they appear to represent one cell type,
viz., SEVC, a term that covers both these morphotypes.
Moreover, the desmoplakin-containing complexus adhaer-
entes are a striking feature common to both SEVC
morphotypes but also occur in certain other endothelial
cells such as in the endothelia of small and medium-sized
lymphatic vessels of, e.g., the dermis and the lingual mucosa
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(Schmelz et al. 1994; Hämmerling 2004; Hämmerling et al.
2006; see also Ebata et al. 2001a, b).
Light and electron microscopy of SEVCs
By light microscopy (for reviews, see, e.g., Raviola 1975;
Wacker 1994; Willard-Mack 2006), subcapsular, interme-
diate, and medullary sinus of mammalian lymph nodes are
characterized by a variably dense meshwork of intraluminal
dendritic virgultar cells, some of which are, at certain
points, connected to the monolayer of sinus-lining endo-
thelial cells (see, e.g., Fig. 1a). The spaces that lie within
the intrasinusal virgultum, and that vary in width depending
on the functional state of the lymph node, contain lymph
fluid and variable numbers of cells, notably macrophages
(specifically sinus histiocytes) and lymphocytes. Often the
SEVCs are difficult to discern at the light-microscopic
level, in particular when the sinus is narrow or when it is
filled with lymphocytes or histiocytes. Cytologically, the
subtypes of SEVCs are inconspicuous, as they usually
possess small nuclei and thin cytoplasmic structures. The
nuclei are usually elongated in the sinus-lining endothelial
cells but are plumper in the virgultar cells. The cytoplasm
of the lining cells is mostly much attenuated, often resulting
in a central nucleus-containing protrusion. The cells of the
intrasinusal virgultar meshwork are characterized by thin,
Fig. 1 Light microscopy and immunohistochemistry of structural
proteins of the sinus endothelial/virgultar cell (SEVC) system in
human lymph nodes, illustrated by the example of a subcapsular sinus
(axillary lymph node, paraffin sections). a–d The capsule (C) lies top
above the subcapsular sinus (brackets). a Hematoxylin and eosin
(H&E) staining. The intrasinusal SEVC meshwork consists of delicate
cells (arrows nuclei of some of these cells) with thin dendritic
processes. Some lymphocytes are seen to be included in the virgultar
meshwork. b Gomori’s silver impregnation. The fine meshwork of
intrasinusal reticulin fibers (arrows) covered by SEVCs and their
processes is visualized. Note the continuity of these fine reticulin
fibers with the thicker fibers of the reticular meshwork of the adjacent
parenchyma (bottom margin). c Immunohistochemistry for collagen
IV. Positive staining of intrasinusal fibers (arrows some cross-
sectioned fibers) and outline of basement membrane beneath the
SEVCs lining the sinus walls. d Cytoplasm of SEVCs is strongly
positive for the intermediate filament protein vimentin. Inset (1.7-fold
higher magnification): SEVC process (arrow) showing a double
contour of vimentin positivity (corresponding to the SEVC process
cytoplasm) ensheathing a negative core corresponding to a reticulin
fiber. Bar 100 µm (in a)
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but often long, branching and anastomosing dendritic
cytoplasmic processes, which occasionally may be up to
100 µm long (see also Wacker 1994), and which are
connected to each other and to the sinus walls.
The free luminal regions in the intrasinusal virgultum are
not merely composed of SEVC processes but are structur-
ally enforced by extracellular collagen bundles that can be
readily visualized as fine fibrils by Gomori’s silver stain
(Fig. 1b; see also Wacker et al. 1997). The fibrilllar network
supporting the intrasinusal SEVC meshwork contains
collagen type IV, as is also demonstrable by immunohisto-
chemistry (Fig. 1c). With van Gieson’s trichrome stain,
however, only a few of the intrasinusal reticular fibers
appear with a faint red stain corresponding to collagen (not
shown). The three-dimensional organization of the virgultar
framework in the lymph node sinus and its association with
the adjacent capsule and parenchyma have been demon-
strated with particular clarity by scanning electron micros-
copy, with and without maceration (Ushiki et al. 1995).
These studies have also clearly demonstrated continuities of
the reticular fiber system from the capsule to the SEVCs
and the parenchyma (as already suggested at the light-
microscopical level by Gomori’s silver stain, see Fig. 1b),
indicating that the virgultar fiber system spanning the sinus
can be considered as part of a continuous skeletal
framework of the lymph node.
By transmission electron microscopy (e.g., Moe 1963;
Forkert et al. 1977; Farr et al. 1980; Sakuma et al. 1981;
Compton and Raviola 1985; Schmelz and Franke 1993;
Wacker 1994; Wacker et al. 1997; Ushiki et al. 1995;
Crivellato and Mallardi 1998), the cytoplasm of SEVCs,
particularly the sinus-lining SEVCs, generally appears
relatively poor in organelles. Often, these cells contain
variable numbers of vesicles, including pinocytotic vesicles
and secondary lysosomes (Moe 1963; Forkert et al. 1977;
Sakuma et al. 1981). Experiments have shown that SEVCs
are able to take up particulate material such as ferritin by
phagocytosis (Farr et al. 1980; Compton and Raviola 1985);
however, they lack the abundant pleomorphic phagosomes
and phagolysosomes characteristic of macrophages (see also
Wacker et al. 1997). At least in some species, plasma
membrane invaginations closed by a diaphragm (Compton
and Raviola 1985) or intracytoplasmic tubulovesicular
structures communicating with the sinus lumen (Crivellato
and Mallardi 1998) have been described in SEVCs.
Furthermore, the SEVCs contain bundles of intermedi-
ate-sized filaments (IFs; Compton and Raviola 1985;
Schmelz and Franke 1993; Wacker 1994; see also below),
which, in mammals, are exclusively of the vimentin type
characteristic of endothelial cells in general (Fig. 1d; Franke
et al. 1979, 1988; Schmelz and Franke 1993; for the
occurrence of cytokeratin IFs in certain endothelial and
other vascular wall cells, see Franke et al. 1989b). These IF
bundles mostly show only limited association with the
plaques of the special cell-cell junctions (complexus
adhaerentes; Schmelz and Franke 1993).
SEVCs are quiescent cells lacking significant prolifera-
tive activity. Mitoses are essentially absent (Wacker 1994),
and the proliferation marker Ki-67, indicative of cells in the
active phases of the cell cycle, is usually detected only in a
few parenchyma-lining SEVCs, i.e., approximately in one
out of 500 cells (Kaiserling et al. 1998).
Especially impressive morphological features of the
intrasinusal SEVCs are their extended, often flat, but broad
cytoplasmic processes, which can almost completely
ensheath the collagenous bundles by the formation of
channel-like plasma-membrane invaginations. By longitu-
dinal closure of the dendritic SEVC processes, which are
supported by complexus adhaerentes, tubes are formed
whose lumina, in which the fibrils run, belong to the
extracellular space (Moe 1963; Crivellato and Mallardi
1998) and are continuous with the extracellular space layer
between sinus-lining SEVCs and fibroblastic reticular cells
(FRCs; see below). These structures, consisting of SEVC
processes and extracellular matrix, represent the virgultum
of the lymph node sinus and will be described in more
detail in “Electron microscopy of cell-cell connections in
the SEVC system”.
Diverse observations have been reported concerning the
presence of a basement membrane or basal lamina structure
adjacent to the abluminal cell surface of the sinus-lining
cells of the SEVC system (see also below). While no such
basal lamina has been reported from rat and rabbit lymph
node sinus (e.g., Farr et al. 1980; Compton and Raviola
1985), Moe (1963) described the presence of an inconstant
basement membrane along the lining SEVCs in mouse
lymph nodes. In human lymph nodes, Forkert et al. (1977)
have reported the presence of a basal lamina supporting the
SEVCs lining the capsule and the trabeculae, whereas an
interrupted basal lamina appears to line the sinus on the
parenchyma side. No basal lamina has been detected on
SEVCs of the medullary sinus. Wacker et al. (1997) have
mentioned SEVC dendrites attached to basal membrane
structures of the sinus walls. Immunohistochemically,
laminin-positive basement membranes have been described
to occur along subcapsular sinus, including their walls
bordering on the parenchyma (Reilly et al. 1985), and also
along the medullary sinus (Pfeiffer et al. 2008).
The SEVCs lining the capsular and trabecular surfaces of
the sinus appear to form a continuous unbroken endothelial
monolayer (Forkert et al. 1977). Moreover, the inner
surfaces of the sinus facing the parenchyma seem to be
extensively lined by SEVCs, except for certain intercellular
gaps the existence of which is, however, controversially
discussed in the literature (cf. Gretz et al. 2000). Whereas
Farr et al. (1980) have not detected any permanent
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apertures in sinus-wall-lining cells in the rat, several other
authors have reported the presence of gaps or pores along
the parenchymatous sides of the sinus in murine (Moe
1963; Sakuma et al. 1981; Ushiki et al. 1995; Crivellato
and Mallardi 1998), rabbit (Compton and Raviola 1985),
and human (Forkert et al. 1977) lymph nodes. Through
these gaps, processes of FRCs (Crivellato and Mallardi
1998) or processes of macrophages/histiocytes have been
described to protrude (Sakuma et al. 1981; Ushiki et al.
1995). Such macrophage processes may capture material
from the lymph and deliver it to immune cells in the
parenchyma (Phan et al. 2007; Junt et al. 2007; Martinez-
Pomares and Gordon 2007). These functional implications
will be described in more detail below (see “Physiological
aspects of SEVCs”).
In general, lymph node sinus appear to be bordered, at
the parenchymatous side, by a trilaminar wall composed of
(1) lining endothelial cells (SEVCs), (2) a layer of
extracellular material including a (partly incomplete) basal
lamina, some collagenous fibrils, and fewer fibrous struc-
tures suggestive of elastic fibers (e.g., Forkert et al. 1977),
and (3) an incomplete layer of flattened FRCs with large
gaps, forming the outer demarcation of the parenchyma.
These FRCs are part of the general dendritic reticular mesh-
work of the lymph node. A subpopulation of FRCs,
designated cytokeratin-positive interstitial reticulum cells
(CIRCs; Franke and Moll 1987; Gould et al. 1995), contains
IFs formed by keratins K8 and K18, and CIRCs may be
included among the perisinusal FRCs.
Desmoplakin and other cytoplasmic plaque proteins
of the complexus adhaerentes
The intense reaction of the SEVCs with desmoplakin
antibodies is remarkably selective, as the reactions for all
other desmosome-specific proteins such as plakophilins 1–
3, desmogleins 1–4, and desmocollins 1–3 have been
consistently negative (Schmelz and Franke 1993; Schmelz
et al. 1994; Hämmerling 2004; Hämmerling et al. 2006).
This is surprising as it defines a special type of cell-cell
adhering junction sui generis, the complexus adhaerens,
which is characterized by the occurrence of desmoplakin as
an abundant component but out of context with the other
desmosome-specific proteins. This is in contrast to the
desmosomes of the near-by FDCs, which contain (in
addition to desmoplakin and plakoglobin) plakophilin-2,
desmoglein-2, and desmocollin-2, i.e. a complete desmo-
somal marker ensemble.
In the SEVCs of the subcapsular, intermediate, and
medullary sinus, one notes, in addition to the desmoplakin
reaction, general and intense immunostaining for a series of
non-desmosomal junctional plaque proteins, such as α- and
β-catenin that colocalize with (or are seen near to)
desmoplakin in structures of various sizes, shapes, and
patterns (“syndesmos” structures; Schmelz and Franke
1993). A typical example is presented in Fig. 2a,a’,b,c.
Careful comparisons of the specific immunostaining pro-
files of the complexus adhaerens structures have shown
colocalization of both desmoplakin and the catenins in
some regions, whereas other sites appear positive only for
one plaque protein or the other. These minor local differ-
ences, however, may simply reflect small local differences
of antigen accessibility. A similarly intense reaction for
desmoplakin, although always in small punctate structures,
is regularly seen in the FDCs of the follicles (F in Fig. 2),
which contain numerous small but complete desmosomes
(Franke and Moll 1987; Nuber et al. 1995; Mertens et al.
1999) and similarly small distinct puncta adhaerentia
junctions (see, e.g., Müller et al. 2000; Hämmerling 2004;
Hämmerling et al. 2006). By contrast, the cells of the
extrafollicular fibroblastic reticulum, FRCs, are negative for
all specific desmosomal components and positive only for
molecular markers of puncta adhaerentia, such as the
catenins (in Fig. 2a, this is shown for β-catenin).
This restriction of desmoplakin to the SEVCs and its
absence from the surrounding FRCs of the parenchymatous
reticulum and from the endothelium of blood vessels is
directly seen in the two-color immunofluorescence micro-
graph of Fig. 3a, which presents a double-label comparison
with β-catenin. Here again, the SEVCs show regions of
colocalization (yellow-orange merged color), whereas other
sites are positive for only one of the two proteins. A similar
situation is presented in Fig. 3b, in which the desmoplakin
reaction of the SEVC junctions is directly compared with
the immunoreaction of protein ZO-1, a characteristic
marker for the cytoplasmic plaques of both adhering and
tight junctions (see also “Tight junction proteins in
complexus adhaerentes”). Moreover, p120 catenin, another
plaque protein of the armadillo family (for reviews, see
Anastasiadis and Reynolds 2000; Hatzfeld 2005; McCrea
and Park 2007), has also been identified in complexus
adhaerens junctions (Fig. 4).
An even broader distribution has been seen with
antibodies against plakoglobin. This armadillo family
protein, which generally can be found in both desmosomes
and adherens junctions of epithelial and endothelial cells
(Cowin et al. 1986; Franke et al. 1987, 1988, 1989a), also
occurs in both the desmosomes and the puncta adhaerentia
of the follicular dendritic reticulum (FDCs), in the puncta
of the interstitial extrafollicular reticulum cells (FRCs), in
the vascular endothelial zonulae adhaerentes, and in the
complexus adhaerentes of the lymph node sinus (see, e.g.,
Hämmerling 2004; Hämmerling et al. 2006).
Reactions for the plakophilins, another subfamily of
junctional plaque proteins of the armadillo type character-
istically occurring in desmosomes, are markedly different
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(for reviews, see Heid et al. 1994; Schmidt and Jäger 2005;
Hatzfeld 2007). In lymph nodes, only the desmosomes of
the FDCs react positively for one of the plakophilins, and
this has been determined to be exclusively plakophilin-2
(Mertens et al. 1999; Hämmerling 2004; Hämmerling et al.
2006).
The occurrence of desmoplakin in the absence of the
other desmosome-specific constituents at endothelial cell
junctions is not restricted to SEVCs of lymph nodes.
Junctions with desmoplakin as a major component have
also been identified in various other lymphatic endothelia,
including small lymph vessels of the dermis and lingual
mucosa (Schmelz et al. 1994; Ebata et al. 2001a, b;
Hämmerling 2004; Hämmerling et al. 2006). Moreover,
desmoplakin has also been identified in endothelial cells of
blood vessels, notably in cell cultures, and appears to be a
Fig. 2 Double-label laser scanning immunofluorescence micrographs of
a cryostat section through a human lymph node, showing the localization
of β-catenin (a) and desmoplakin (a’) in the SEVCs of the sinus (S; left
bracket in a’) and in dendritic reticulum cells (FDCs) of the follicle (F;
right bracket in a’ denoting the germinal center), both of which are
positive for both proteins, whereas blood vessels (two are denoted by
arrowheads) are only β-catenin-positive. Note, in particular, the
frequency of desmoplakin-positive SEVC protrusions extending into
the lumen of the sinus, often ensheathing collagen fibril bundles (b-d
details of desmoplakin immunostaining in such cell projections). The
boxed cross-sectioned cell in a’ is shown at higher magnification in d
and represents a prototypic example of a virgultar meshwork cell with
processes that span the entire sinus. Middle bracket in a’, follicular
mantle zone. Bars 50 µm (a, a’, b), 25 µm (d), 10 µm (c)
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protein of general importance for vascular development
(Valiron et al. 1996; Kowalczyk et al. 1998; Gallicano et al.
2001; Zhou et al. 2004; for reviews, see also Sleeman et al.
2001; Stacker et al. 2002; Ferreri and Vincent 2008).
Cadherins in complexus adhaerentes and other endothelial
junctions of lymph nodes
As the SEVCs do not contain any of the typical
desmosomal cadherins, i.e., desmogleins and desmocollins,
the question of the transmembrane glycoproteins involved
in the formation and maintenance of the complexus
adhaerentes and, in particular, their cytoplasmic plaques is
of central molecular and organizational importance. Again
surprisingly, in our hands, the complexus adhaerens
structures and the entire SEVCs have been negative for
N-cadherin (Fig. 5), which, in the same sections, is
constantly and intensely seen in the punctate adhering
junctions of both kinds of reticulum cells, viz., the FDCs
and extrafollicular FRCs, and in the vascular endothelial
cell junctions (Hämmerling 2004; Hämmerling et al. 2006;
for partly controversial views of the topology and functions
of N-cadherin in adhering junctions of blood vessel
endothelia, see, e.g., Salomon et al. 1992; Lampugnani et
al. 1995; Dejana 1996, 2004; Lampugnani and Dejana
1997; Navarro et al. 1998; Luo and Radice 2005; for a
Fig. 3 Double-label immunofluorescence laser-scanning microscopy
(LSM) of desmoplakin (a, b red) compared with the adherens junction
protein β-catenin (a, green) or the adherens and tight junction-
associated protein ZO-1 (b, green). Desmoplakin and β-catenin
colocalize in SEVCs of the sinus (S) at many sites (yellow-orange
merge color) but are not fully coincident (a). The double-label staining
of desmoplakin and protein ZO-1 in the sinus (S) also shows some
sites of local colocalization (b). Blood vessel (V) walls are positive
only for β-catenin (a) or protein ZO-1 (b). Bars 50 µm
Fig. 4 Immunofluorescence localization of the junction plaque
armadillo protein p120 catenin in the SEVCs (S sinus) and in blood
vessels (V) in a cryostat section of a human lymph node. Bar 50 µm
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claim of the coexistence of both N- and E-cadherin in
cultured rat microlymphatic cells, see Hayes et al. 2003).
In stark contrast, there is an intense reaction of VE-
cadherin (cadherin 5) not only in the endothelia of blood
vessels of lymph nodes, but also in all SEVCs, in the latter
often in apparent colocalization with desmoplakin (Fig. 6a,
b; for an indirect comparison with α-catenin, see Fig. 6c).
We are therefore tempted to hypothesize that, in the
complexus adhaerentes of SEVCs (and of lymphatic vessel
endothelia), desmoplakin is involved in the anchorage, the
homophilic association and lateral clustering, and the
homotypic Ca2+-dependent cell-cell interactions of VE-
cadherin (for some corresponding observations, see also
Vittet et al. 1997; Ahrens et al. 2003), be it directly or
through complexes with α-catenin or any of the armadillo
proteins present (see, e.g., Breviario et al. 1995; Caveda et
al. 1996, Carmeliet et al. 1999; and references cited
therein).
Again, the reaction pattern of cadherin-11, which in
other cells often occurs in coexistence with N-cadherin (e.g.
Hinz et al. 2004; Wuchter et al. 2007; and references cited
therein), including various cell types in lymph nodes
(Hämmerling 2004), has been unexpected, as it is selec-
tively negative on SEVCs (Fig. 7). The significance of this
negative reaction has been controlled by the highly intense
reactions of cadherin-11 in the trabecular fibroblastoidal
cells (T in Fig. 7) and in the various interstitial cells of
mesenchymal character located between the follicles and
the sinus, including the FRCs (Fig. 7). It has also not
escaped our attention that the trabecular cadherin-11
immunostaining correlates with an intense and specific
reaction for certain collagen types (data not shown).
Cadherin-11 is generally of widespread occurrence in
diverse mesenchymal cell types, but neither in gene
abrogation experiments nor in analyses of specific genetic
mutations have definitive functions of this glycoprotein so far
been elucidated to a satisfactory degree (e.g., Simonneau et al.
1995; MacCalman et al. 1996; Shibata et al. 1996;
Simonneau and Thiery 1998; Horikawa et al. 1999; Hinz et
al. 2004; Wuchter et al. 2007), except for some special roles
in osteogenesis, chondrogenesis, and tendon development (e.
g., Kawaguchi et al. 2001a, b; Luo et al. 2005; Richardson et
al. 2007).
So far, we have been unable to localize protocadherin-
12, i.e. VE-cadherin-2 (Telo’ et al. 1998; Rampon et al.
2005; see therein for further references), in any lymph node
cell type. Another endothelial cadherin, cadherin-13 (pre-
viously also called V-cadherin; Haselton and Heimark
1997), has been reported in a subset of SEVCs of both
human and bovine lymph nodes, but the significance and
specificity of this reaction has not yet been ascertained
(Schmelz and Franke 1993; Schmelz et al. 1994).
Therefore, we conclude that the complexus adhaerentes
of SEVCs appear to be the only type of endothelial cell
junctions based exclusively on VE-cadherin, i.e., without
N-cadherin. Consequently, we consider it unlikely that, in
the SEVC part of the vascular endothelial system, N-
cadherin plays a master role in controlling VE-cadherin
synthesis and functions, as has been proposed for other
parts of the endothelial system by Luo and Radice
(2005).
Proteins of the afadin ensemble
Using antibodies against proteins of this group, which
include plaque proteins such as afadin and transmembrane
components such as nectin (for a review, see Takai and
Nakanishi 2003), we have obtained an intense reaction in
SEVCs only for afadin, partly also in colocalization with
desmoplakin (Fig. 8). Reactions for other proteins of this
group, however, have so far been negative or their
Fig. 5 Double-label LSM of a cryosection through a human lymph
node, showing colocalization of the adherens junction protein N-
cadherin (red) and desmoplakin (green) in the follicular (F) dendritic
reticulum. Note that, at the light-microscopic level, the yellow merge
color represents the close apposition of the small puncta adhaerentia
and desmosomes in the FDCs. The desmoplakin-positive SEVC
system of the sinus (S) does not reveal significant reactions of N-
cadherin, whereas the surrounding interstitial reticulum cells (mostly
FRCs) are positive for N-cadherin, but not for desmoplakin. Bar
50 µm
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significance has not yet been definitively determined
(Hämmerling 2004).
Tight junction proteins in complexus adhaerentes
Certainly one of the greatest surprises in our analyses of the
molecular composition of the complexus adhaerentes has
been the discovery of the general occurrence of claudin-5
(Fig. 9a–d; see also Hämmerling et al. 2006), the hallmark
protein of the endothelial tight junction. This tetraspan
transmembrane protein is also present in cell-cell junctions
of endothelia of blood vessels but is totally absent from all
other lymph node structures, including the FDCs and the
FRCs (Fig. 9a,a’). In the SEVCs, we have noted a wide-
reaching but not complete overlap of claudin-5 immuno-
fluorescence with that of desmoplakin, which defines the
complexus adhaerens structures (Fig. 9a,a’,b,b’). Generally,
the reaction for claudin-5 appears more extended and linear
than that of desmoplakin (Fig. 9c,d; cf. Hämmerling 2004).
Meanwhile, claudin-5 has also been identified in endothelia
Fig. 6 Double-label immunofluorescence LSM of cross sections
through frozen tissue of human lymph nodes, showing the specific
mutually exclusive localization of VE-cadherin (a, red) in the
endothelium of small blood vessels (V) and the punctate staining for
desmoplakin (a’, green) in the dendritic reticulum cells (FDCs) of the
follicle (F). Colocalization of desmoplakin and VE-cadherin, however,
is seen in the complexus adhaerentes of the SEVCs of the sinus (S), as
can be seen with special clarity (yellow) in the merged image (a’’; for
a merged image at higher magnification, see b). A corresponding
merged image showing colocalization of desmoplakin (red) and α-
catenin (green) is presented in c. Bars 50 µm
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of other parts of the lymphatic system (Baluk et al. 2007;
Pfeiffer et al. 2008). Occasionally a weak reaction of
claudin-1 in SEVCs has also been seen with a rabbit
antiserum but the significance of this observation has
not yet been ascertained by the use of other reagents
(Hämmerling 2004). In mouse SEVCs, in which claudin-5
has recently been confirmed, no claudin-1, claudin-3, or
claudin-12 has been detected (Pfeiffer et al. 2008). Finally,
we are aware that the discussion as to the occurrence of the
transmembrane protein occludin in SEVC structures is also
still controversial (see Table 1; see also Baluk et al. 2007;
Pfeiffer et al. 2008; and references cited therein).
Further tight-junction-associated proteins identified in
association with the complexus adhaerentes of SEVCs
include members of the junctional adhesion molecule
Fig. 7 Double-label immunostaining LSM of cadherin-11 (red) in the
fibroblastoidal cells forming the connective tissue of a trabecula (T),
whereas the SEVC system (S, intermediate sinus) is distinctly positive
for desmoplakin only (green). Note also positive immunoreaction of
the cadherin-11 antibodies in the interstitial cells of the reticulum
(mostly FRCs) that surrounds the sinus. Bar 50 µm
Fig. 8 Double-label LSM comparing the immunolocalization of the
plaque protein L-afadin (a, red) with that of desmoplakin (a’, green),
which colocalize in the SEVCs of the two sinus (S) of a human lymph
node. Note the distinct immunostaining of the small blood vessels (V)
by L-afadin (in a and in the merged picture a’’). Bar 50 µm
Fig. 9 a, a’, b, b’ Double-label immunolocalization LSM on cryostat
sections through human lymph nodes, showing that the tight junction
protein claudin-5 (a, b) and desmoplakin (a’, b’) colocalize in SEVCs
of the sinus (S), whereas the follicle (F) shows positive staining for
desmoplakin only, which is specific for the desmosomes of the FDCs.
Blood vessels (V) are positive for claudin-5, which is known as a tight
junction protein characteristic of vascular endothelia. c, d Immuno-
histochemical demonstration of claudin-5 in a paraffin-embedded
human pelvic lymph node (c), compared with desmoplakin staining
(d), showing an intermediate sinus (c, V capillary blood vessel in a
trabecula) and a medullary sinus (d) with a degree of sinus
histiocytosis and hyperplasia of SEVCs. Note the predominantly
linear claudin-5 staining of SEVCs (c) as opposed to the predomi-
nantly punctate desmoplakin staining (d). Bars 50 µm (a, a’, b, b’),
100 µm (c, d)
b
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(JAM) family, transmembrane molecules of the immuno-
globulin superfamily. In endothelia of blood and lymphatic
vessels, two or all three archetypal JAM proteins (JAM-1 to
JAM-3/JAM-A to JAM-C; for nomenclature, see, e.g.,
Mandell and Parkos 2005) have been demonstrated (Aurrand-
Lions et al. 2001; Ueki et al. 2008; for details, see Pfeiffer et
al. 2008). In SEVCs of human and bovine lymph nodes,
JAM-1 (i.e., JAM-A) has been consistently detected in our
laboratory (Hämmerling et al. 2006). In mouse lymph nodes,
both JAM-1 (JAM-A) and JAM-2 (JAM-C) have been
reported in cells of the subcapsular sinus (Aurrand-Lions et
al. 2001), which most likely represent subcapsular SEVCs.
Recently, the presence of JAM-A and JAM-C in subcapsular
and medullary sinus-lining cells has been confirmed by
double-label immunostaining experiments, whereas JAM-B
has been reported to be absent (Pfeiffer et al. 2008). Since,
among the JAMs, only JAM-2 (JAM-C) seems to be
restricted to endothelial cells (Aurrand-Lions et al. 2001), it
may serve as an additional endothelial marker, at least in the
mouse. In this species, another endothelial tight junction
molecule related to the JAMs, viz., endothelial-cell-selective
adhesion molecule (ESAM)-1, has also recently been iden-
tified in SEVCs (Pfeiffer et al. 2008) and proposed to be
involved in cell migrations through the sinus-lining cell layer.
Finally, SEVCs produce the plaque protein ZO-1 (Fig. 3;
cf. Hämmerling et al. 2006), which also occurs as a general
component in the lymphatic endothelium (Hämmerling et
al. 2006) and in tight and adhering junctions of blood
vascular endothelial cells (Dejana 2004). Thus, SEVCs
contain a set of tight junction proteins that overlaps with that
found generally in lymphatic and blood vessel endothelia,
with the possible exception of occludin. We should, however,
mention, as a note of caution, that the exact spatial
relationship of the tight junction elements to the total
complexus adhaerens structures is not yet clear (Hämmerling
et al. 2006), and hence more detailed immunoelectron-
microscopical and biochemical investigations are required.
Specifically, at present, we cannot rule out the possibility
that these tight-junction-typical transmembrane proteins are
concentrated in a narrow curvilinear intramembranous “ridge”
confinement of the complexus. Moreover, the importance of
the tight junction proteins for the barrier versus permeability
functions of the SEVCs remains to be elucidated.
Table 1 summarizes the unique pattern of major
molecular components constituting complexus adhaerentes
in comparison with the molecular composition of adhering
junctions of blood vessel endothelia. Complexus adhaerentes
are therefore specifically characterized by the presence of
desmoplakin together with the absence of N-cadherin and
protein p0071.
Electron microscopy of cell-cell connections
in the SEVC system
In the lymph nodes of the mammalian species examined so
far, the sizes and architectural organization patterns of the
complexus adhaerens structures of SEVCs differ markedly.
Frequently, the relatively large junctional arrays character-
ized by their typical electron-dense cytoplasmic plaques
show local interruptions of variable sizes, shapes, and plaque
coating. Figure 10 illustrates this in a series of eight
consecutive ultrathin sections (four of them shown), reveal-
ing small plaque-free regions (some are denoted by arrows).
Detailed morphological and morphometrical studies, includ-
ing image reconstructions, have previously been published
(e.g., Schmelz and Franke 1993; Franke et al. 1994; Schmelz
et al. 1994). Notably, bundles of typical actin microfilaments
or of IFs of the vimentin type (Franke et al. 1979) often lie
close to these plaques, sometimes suggestive of “loose”
lateral association rather than of terminal anchorage.
Figure 11 presents a series of images showing the often
winding and deeply interdigitating regions of these com-
plex adhering junctions, frequently with small or larger
interruptions of the plaque-coated plasma membranes (e.g.,
Fig. 11a,e–g,h,h’; note that similar junctional arrays,
including those with multiple deep interdigitations, also
occur in other vascular endothelia; for a review, see Franke
Table 1 Major molecular components of the complexus adhaerentes
connecting sinus endothelial cells (SEVCs) of mammalian lymph
nodes, a comparison with vascular adhering junctions
Complexus adhaerentes of SEVCs
of lymph node sinus













p120 Catenin p120 Catenin
Plakoglobin Plakoglobin
Protein ZO-1 Protein ZO-1
L-afadin L-afadin
aWe have noticed weak and locally restricted positive immunocyto-
chemical reactions for occludin only in some cells and not with all the
antibodies applied. Similarly, we have occasionally but not generally
seen faint local reactions with antibodies to claudin-1 and claudin-12,
the significance of which has not yet been ascertained (see also
Hämmerling 2004; Hämmerling et al. 2006; for corresponding
controversial reports, see also Nitta et al. 2003; Pfeiffer et al. 2008).
As to the question of the occurrence of JAM-B and JAM-C in these
cells, see Ebnet et al. 2003; Pfeiffer et al. 2008.
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et al. 1988). In some regions, these plaques show
remarkable local fluctuations in size and electron density,
often suggestive of a higher order organization of more or
less closely-packed plaque elements (Fig. 11b–d). In other
regions, such cell-cell junction complexes appear as
individual domains with widely variable diameters (e.g.,
Fig. 11e). In some plasma membrane convolutions, the
local packing density of the associated bundles of micro-
filaments and vimentin IFs is high (see Fig. 11c,e,f).
Irrespective of the specific size and morphology of these
complex junctions, immunoelectron microscopy has gener-
ally shown positive reactions for desmoplakin (e.g.,
Fig. 11i–k), β-catenin, and any of the other complexus
adhaerens components examined (data not shown).
As the architecture of a specific sinus appears to be
influenced by the position, thickness, and length of the
trabecular structures and corselet-like “stays” of paracrystalline
collagen fiber bundles extending into the luminal spaces, we
have taken special care to elucidate the intimate relationship
between these semiplastic collagen and elastin fibril bundles
and the surrounding SEVC processes (for earlier electron
microscopy, see Moe 1963; Forkert et al. 1977; Compton and
Raviola 1985; Yoshida and Takaya 1992; Wacker 1994;
Crivellato and Mallardi 1998). Our major findings are
summarized in Fig. 12, showing a tomographic stack of
electron micrographs of cross sections through such a
paracrystalline bundle comprising, in this case, ten collagen
fibers, lying closely together with near equidistant spacing, in
six sections of a total series of ten. The entire length of this
collagen fiber bundle, with some surrounding loose arrays of
elastin fibrils, is ensheathed by a manchette of flattened
virgultar cell processes that are tightly connected by a
complex of small adhering junctions (Fig. 12a–f, arrow-
heads). The plaque-bearing portions of these puncta adhaer-
entia-like junctions mostly appear to be closely attached,
whereas in other small regions plaque-free areas can also be
discerned (Fig. 12c–f). From such electron micrographs and
the desmoplakin immunostaining, we conclude that the
collagen-fiber-based “stay” structures of lymph node sinus
are, over large areas, tightly enveloped by SEVC processes
and “stitched” together by complexus adhaerentes. In most of
the cases examined, the endothelial processes forming
extended manchettes resemble the “fibripositors” that have
been described with respect to the relationship of fibroblast
cell protrusions and collagen fibril bundles in tendon
formations (Canty et al. 2004, 2006; Richardson et al. 2007;
see also Birk and Trelstad 1986).
For the sake of clarity, we should emphasize that these
collagen fibril bundle arrays ensheathened by manchette-
like cell processes should not be confused with the
collagen-based reticular fibers that are only surrounded by
elastin fibers, with or without several typical basement-
membrane-specific components but not with cell processes
(see, e.g., Kramer et al. 1988; Hayakawa et al. 1990).
In summary, the complexus adhaerens is a unique,
extended, complex, variously sized and shaped junction
structure covering large parts of adjacent cell borders. This
is illustrated in Fig. 13, which presents a “typical”
tomographic reconstruction model (cf. Schmelz and Franke
1993) showing a small section of a syndesmos structure
connecting two SEVCs in the sinus of a bovine lymph node.
Complexus-adhaerens-related junctions in other parts
of the lymphatic vessel system
The typical variously sized and shaped complexus adhae-
rens (see representation in Fig. 13) is a characteristic
Fig. 10 Electron micrographs presenting a series (a-d) of consecutive
ultrathin sections through a region of a bovine lymph node in which
SEVCs are attached to each other (numbers lower right give the
specific section number in the series). The two cells shown are
connected by a large complexus adhaerens, characterized by a dense
cytoplasmic plaque and an irregular pattern of plaque interruptions
(see arrows in b, c). Bar 0.5 µm
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structure of SEVCs of the lymph node sinus. By using,
however, desmoplakin as an immunohistochemical marker
protein in a search for complexus-adhaerens-related endo-
thelial junctions in other tissues, such structures have also
been identified in several parts of the lymphatic vessel
system in the various mammalian species studied, in
particular in the spleen and in small lymphatic vessels of
the dermis, of the submucosae of various organs, and of
muscle tissue (Schmelz et al. 1994; see also Ebata et al.
2001a, b). These observations have recently been extended
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to further junctional molecules and related to certain
lymphatic functions and pathogenic processes (cf. Baluk
et al. 2007; Pfeiffer et al. 2008). In view of the general
importance of the lymphatic system in homeostasis and in
pathogenic processes, notably in cancer metastasis (for
recent reviews, see Stacker et al. 2002; Al-Rawi et al. 2005;
Alitalo et al. 2005), the crucial contributions of the lymphatic
endothelial junctions in general and in the lymph node sinus
in particular should now be elucidated by using specific
molecular markers as a morphology-independent criterium
(cf. Table 1).
Endothelial cell type markers in SEVCs
As the endothelial nature of the lymph node SEVCs has
been repeatedly doubted or even denied (for reviews, see
Wacker 1994; Gretz et al. 1997; Willard-Mack 2006), we
have characterized these cells by immunohistochemistry
with specific molecular markers for endothelial cells in
various mammalian species (cf. Schmelz and Franke 1993;
Hämmerling 2004; for lymphatic endothelial markers, see
also Podgrabinska et al. 2002). Table 2 summarizes our
findings and those of other authors. The occurrence of
endothelium-specific cell junction proteins such as VE-
cadherin, claudin-5, and JAM-2/JAM-C (mouse) in SEVCs
has previously been mentioned (see Table 1). With respect
to classical endothelial cell markers (Table 2), a typical
result showing double-label immunofluorescence micros-
copy of the factor-VIII-related antigen (von Willebrand’s
factor) and desmoplakin is presented in Fig. 14a,b. Clearly,
the desmoplakin-positive SEVCs are also positive for the
factor-VIII-related antigen (Schmelz and Franke 1993). The
significance of this reaction is underscored by the absence
of the factor-VIII-related antigen in the desmosome-
positive FDCs. Vice versa, however, the blood vessel
endothelial cells in the lymph node parenchyma are positive
for factor-VIII-related antigen but negative for desmoplakin
(Fig. 14a,b). In contrast to the junctional pattern of
desmoplakin, immunostaining for factor-VIII-related anti-
gen typically exhibits a finely granular cytoplasmic appear-
ance (Fig. 14a,c; Schmelz and Franke 1993; for electron
microscopy of factor-VIII protein in endothelial cells, see,
e.g., Simionescu and Simionescu 1988). Remarkably,
whereas in blood vessel endothelium, this staining is
mostly strong and uniform, in SEVCs, it often appears
weaker and more variable (Fig. 14b; see also Schmelz and
Franke 1993; Krenács and Rosendaal 1995). In addition to
the distinct granular staining, some SEVCs, both in bovine
lymph nodes (Fig. 14a) and in human lymph nodes from
diverse sites, including pelvis (Fig. 14b,c), abdomen and
axilla (not shown), exhibit factor-VIII-related antigen as
conspicuous, densely stained, paranuclear aggregates, an
aspect that remains to be clarified by immunoelectron
microscopy. To the best of our knowledge, Weibel-Palade
bodies, which harbor factor-VIII-related antigen in combi-
nation with other factors important for blood coagulation in
blood vessel endothelial cells (Simionescu and Simionescu
1988), have not yet been mentioned in ultrastructural
studies of SEVCs.
A further general endothelial cell marker, which also
has been noted in certain blood and immune cells
including macrophages, is the transmembranous glyco-
protein CD31, also known as platelet endothelial cell
adhesion molecule-1 (PECAM-1). In endothelial cells,
this cell adhesion molecule of the immunoglobulin (Ig)
superfamily, which sometimes appears to be enriched at
cell-cell junctions, seems to serve multiple functions
including transendothelial migration of leukocytes, angio-
genesis, and apoptosis (Jackson 2003). It is also found in
endothelial cells of lymphatic vessels, although the
staining intensity is weaker in comparison with the blood
vessel endothelium (Ebata et al. 2001b). Antigen CD31
has also been reported to occur in SEVCs of human and
mouse lymph nodes (human: Ruco et al. 1992; Krenács
and Rosendaal 1995; mouse: Aurrand-Lions et al. 2001;
Singer et al. 2005), although Wacker et al. (1997) have not
detected it in human sinus-lining cells on cryostat
sections. Previously, we have reported strong staining of
SEVCs of human lymph node sinus with monoclonal
antibody EN4 (Schmelz and Franke 1993), which has
been shown to recognize CD31 (Burgio et al. 1994).
When we compared sections of human lymph nodes
stained for desmoplakin with CD31 immunostaining in
subsequent sections, we found CD31 consistently in all
SEVCs, with mostly linear staining of the cell surfaces
(Fig. 15a; see also below). In addition to desmoplakin and
claudin-5, CD31 can thus be used as a sensitive marker of
the SEVC system in lymph nodes. The functional roles of
CD31 in SEVCs might include the adhesion and transmi-
gration of leukocytes.
Fig. 11 Electron micrographs of ultrathin sections through various
syndesmos structures of complexus adhaerentes, showing adhering
junctions of human and bovine SEVCs (a-h’) and the localization of
desmoplakin (i-k), in conventional (a-h’) and immuno- (i-k) electron
microscopy (C collagen fibers). a-h’ The often convoluted complexus
adhaerentes appear in some places as large continuous structures (b),
whereas in others, small substructures can be recognized (c, arrows;
see also d). They sometimes appear as a complex of larger and smaller
puncta adhaerentia-like structures (arrowheads in e; see also the
substructures discernible in f). Note the beginning and the end of a
cell-cell-contact (thin arrows in g) that seems to be composed of
variously sized subdomains (arrowheads). Two adjacent ultrathin
sections of a series (h, h’) demonstrate local differences in complexus
adhaerentes (arrows). The basal lamina is denoted by thick arrows
(bottom) in e–g. i-k Immunogold-silver enhancement reaction,
showing the plaque localization of desmoplakin in the complexus
adhaerens structures. Bars 0.5 µm (a, c–g, i), 0.2 µm (b, h, h’,k),
1 µm (j)
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CD34 is a sialomucin constitutively produced in most blood
vascular endothelial cells and, as an L-selectin ligand, is
involved in the binding of leukocytes. As to the lymphatic
vascular system, CD34 appears to be absent from lymphatic
endothelium in normal tissue, whereas it is prominent in
endothelial cells of lymphatic vessels of tumors and of
chronically inflamed tissues and thus may be regarded as an
activation marker antigen of human lymphatic endothelial cells
(Fiedler et al. 2006). In SEVCs of human lymph nodes, we
detected CD34 only at low degree and usually only a small
subset of these cells was positively immunostained (Fig. 15b).
In some lymph nodes, the SEVCs were completely CD34
negative, and we did not observe any correlation between the
CD34 status of SEVCs and the activation or regression state
of the lymph nodes (Sievers 2009).
When analyzing thrombomodulin (CD141), a cofactor
for the thrombin-mediated activation of protein C (Suzuki
et al. 1987) and another marker for blood and lymphatic
vessel endothelia, we observed a remarkable expression
pattern. A variable subpopulation of SEVCs, with some
preference of sinus-lining SEVCs, was intensely stained
with anti-thrombomodulin antibodies, as were some
adjacent perisinusal cells in the parenchyma probably
representing FRCs (Fig. 15c).
Fig. 12 a-f Electron micro-
graphs showing six images
from a series of ten consecutive
cross sections through one of the
typical “stays” of collagen fiber
bundles (arrow) tightly enwrap-
ped by cytoplasmic
projections of SEVCs. The
paracrystalline bundle of ten
collagen fibers shown here is
intimately surrounded by
projections from two cells
forming an extended array of
complexus adhaerentes (distinct
substructures are denoted by
arrowheads). Note that the
collagen-fiber-containing canal
also harbors thinner filamentous
structures. Bar 0.3 µm
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Other endothelial components examined, including
CD105 (also known as endoglin; Duff et al. 2003) and
CD143 (also known as ACE, i.e., angiotensin converting
enzyme; Danilov et al. 1991), distinctly reacted only with
certain subsets of blood vessel endothelial cells. We did not
detect these markers on SEVCs (not shown). Binding of the
lectin Ulex europaeus agglutinin-I (UEA-I), a further
marker of blood vessel endothelial cells, was negative in
the sinus of the lymph nodes studied, and here, in contrast
to vascular and lymphatic endothelia, SEVCs apparently
did not bind UEA-I (not shown; see also Wacker 1994). On
the other hand, SEVCs have been reported to be positive
for BMA 120, another marker of blood vascular endothelial
cells (Kaiserling et al. 1998). Thus, one can conclude that
SEVCs present several fundamental markers of blood
vascular endothelial cells, whereas others appear only as
minor elements or are absent.
Several specific markers of lymphatic endothelial cells
have recently become available that are of particular
interest with respect to SEVCs as a part of the lymphatic
vascular system. An especially striking and specific
example is provided in Fig. 16a, showing a double-label
immunofluorescence microscopic comparison of desmopla-
kin with the lymphatic marker protein LYVE-1 (lymphatic
vessel endothelial hyaluronan receptor-1; cf. Banerji et al.
1999; Podgrabinska et al. 2002). Whereas the SEVCs in the
sinus are positive for both LYVE-1 (see also Jackson et al.
2001; Wróbel et al. 2005; Hämmerling et al. 2006; for the
mouse, see Phan et al. 2007) and desmoplakin, the FDCs
are exclusively positive for desmoplakin (Fig. 16a). In
some cases of paraffin-embedded human lymph nodes,
LYVE-1 staining of SEVCs has been markedly heteroge-
neous, in contrast to homogeneous staining of lymphatic
vessel endothelium (not shown). Further support for the
true lymphatic endothelial character of SEVCs is provided
by our finding (Fig. 16b) that these cells stain positively for
vascular endothelial growth factor receptor-3 (VEGFR-3,
FLT4), a molecule involved in the development of
lymphatic endothelia (Kaipainen et al. 1995). Another
widely used lymphatic endothelial marker is podoplanin, a
small extensively O-glycosylated membrane glycoprotein
essential for the development of lymphatic vessels and
established as a marker to discriminate between blood and
lymphatic endothelial cells (Breiteneder-Geleff et al. 1999).
Here, we detected podoplanin by using monoclonal
antibody D2–40, which has recently been reported to
recognize human podoplanin specifically (Schacht et al.
Table 2 Endothelial marker molecules in SEVCs of mammalian lymph nodes




+b Schmelz and Franke 1993; Krenács and Rosendaal 1995
CD31 (PECAM-1) + Ruco et al. 1992; Schmelz and Franke 1993c; Krenács and Rosendaal 1995; Aurrand-Lions et al.
2001; Singer et al. 2005
CD34 –/+ Present paper
Thrombomodulin (CD141) +/– Present paper
BMA 120 + Kaiserling et al. 1998
Lymphatic endothelial markers
LYVE-1 +/– Jackson et al. 2001; Wróbel et al. 2005; Hämmerling et al. 2006; present paper
VEGFR-3 + Present paper
Podoplanin (D2–40) –/(+) Present paper
a Immunohistochemical distribution pattern: + homogeneously positive, +/– majority of SEVCs positive, –/+ minority of SEVCs positive, –/(+)
very few SEVCs positive
bWeaker staining as compared with blood vessel endothelium, and a few SEVCs may be negative
c As detected by monoclonal antibody EN4 (cf. Burgio et al. 1994)
Fig. 13 Computer-aided model reconstructed from electron micro-
graphs of a tomographic series of sections through an extended
syndesmos region between two virgultar SEVCs in the sinus of a
lymph node. Plasma membranes of the cells are shown in blue; one of
the cytoplasmic plaques of the junction is shown in purple. Note the
fenestrated structure and the extent of the cytoplasmic plaque (from
Schmelz and Franke 1993)
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2005), and obtained variable results in SEVCs. Whereas
endothelia of small perinodal lymphatic vessels were
consistently positive (Fig. 16c), abundant podoplanin
staining of SEVCs (Fig. 16c) was the exception, with
usually only occasional SEVCs being immunostained (cf.
Fig. 16d).
Thus, based on the presence of a distinct spectrum of
general endothelial markers and several lymphatic endo-
thelial markers (Tables 1, 2), SEVCs should be regarded as
a special subtype of endothelial cells related to but not
identical with lymphatic vessel endothelium.
With respect to the differences in molecular composition
between the adhering junctions connecting endothelial cells
of blood vessels, on the one hand, and the complexus
adhaerentes of the SEVCs, on the other (cf. Table 1), the
most remarkable is certainly the presence of desmoplakin in
the adhering junctions of SEVCs (see Figs. 2, 3, 5, 6, 7, 8,
9, 14, 16, and below) and the absence of significant
Fig. 14 Localization of the endothelial marker, factor-VIII-related
antigen (a), in comparison with that of desmoplakin (a’) in double-
label LSM of an acetone-fixed cryosection of a bovine lymph node
and in immunohistochemical staining of paraffin sections of human
lymph nodes (b, c). C capsule. Both factor VIII protein and
desmoplakin occur in SEVCs (S sinus). In addition, exclusive staining
of blood vessels (V) is seen for factor VIII protein, whereas
desmoplakin also occurs in the small desmosomes of the follicular
(F) dendritic reticulum (lower right in a’). Note that both factor-VIII-
related protein and desmoplakin can occur in the same SEVCs,
although in obviously different cell substructures (e.g., plaque-like
immunoreactivity indicated by arrows in a). Immunostaining of
formalin-fixed and paraffin-embedded iliac lymph nodes (b, c) for
factor-VIII-related antigen is strong in blood vessel endothelium (V)
but often weaker and more heterogeneous in SEVCs (bracket in b
subcapsular sinus), with some SEVCs apparently being negative (cf.
Schmelz and Franke 1993), whereas variable numbers of SEVCs
exhibit a conspicuous plaque-like immunoreactivity (b, c; some
aggregates are denoted by arrows). Bars 50 µm (a, a’), 100 µm (b, c)
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amounts of protein p0071 in these cells, as emphasized by
results of their double-label immunoreaction (Fig. 17). In
contrast, p0071 is readily detectable in the vascular
endothelia of vessels of diverse calibers (Fig. 17, arrows;
see also Hofmann et al. 2008). The presence of protein
p0071, which is a catenin-type protein of the armadillo
family and a constituent of various types of adhering
junctions (Hatzfeld and Nachtsheim 1996; Hatzfeld 2005),
including vascular endothelia (Calkins et al. 2003), now
provides a surprising difference between blood vessel and
lymphatic endothelia. We thus suggest the use of p0071 as
a molecular marker for a subset of endothelia, but ex-
cluding the SEVC system.
In addition to the various endothelial markers, several
other biologically important antigens have been detected in
SEVCs, including connexin 43 (Cx43), a component of
gap junctions, which appears in a distinct dotted immunos-
taining pattern in these cells and in FDCs (cf. Krenács and
Rosendaal 1995). SEVCs are also stained by Ki-M9, a
monoclonal IgM antibody recognizing a unique membrane-
bound protein of 70 kDa with a short half-life (Wacker et al.
1997; Middel et al. 2002). This antibody also more weakly
stains FDCs, and on the basis of these and other data,
Wacker et al. (1997) have postulated an ontogenic
relationship between SEVCs and FDCs and a possible
function of SEVCs as antigen-presenting and accessory
cells in the primary humoral immune response (Wacker et
al. 1997; Middel et al. 2002). Another feature that SEVCs
share with FDCs is the binding of the lectin Chelidonium
majus agglutinin (CMA), but other cell types in lymph
nodes, including FRCs and blood vessel endothelial cells,
also produce carbohydrate moieties that bind to CMA
(Düllmann et al. 2002). Moreover, cells of the medullary
sinus, probably SEVCs, have been described to be positive
with a monoclonal antibody to langerin (CD207; Chikwava
and Jaffe 2004), a type II lectin specific for antigen-
capturing, -processing, and -delivering Langerhans cells.
The same has been found for the lining cells of hepatic
sinusoids. Both sinus-lining cell types lack, however, the
Langerhans cell antigen CD1a. Moreover, S-100 protein,
typically present in Langerhans cells and interdigitating
dendritic cells (IDCs), is absent from SEVCs. Certain
antigens characteristic of hematopoietic cells may also be
present in SEVCs. Thus, CD45 (leukocyte common
antigen), a transmembrane glycoprotein expressed on most
nucleated cells of hematopoietic origin, may be found
immunohistochemically on the surface of a subpopulation
of SEVCs (not shown). This has previously also been been
Fig. 15 Immunostaining of SEVCs by endothelial markers as
demonstrated in a subcapsular sinus of human formalin-fixed and
paraffin-embedded abdominal (a), axillary (b), and cervical (c) lymph
nodes (C capsule, S subcapsular sinus, V small blood vessels with
their endothelial cells markedly positive for all three antigens).
Antigen CD31 (a; clone JC70A) appears in an extended, predomi-
nantly linear, surface staining of both the sinus-lining and the virgultar
SEVCs and their cell processes, whereas staining for CD34 (b; clone
QBEND-10) is much more restricted to a minor subpopulation of
SEVCs (other areas are completely negative; not shown). Thrombo-
modulin (CD141; c; clone 1009) reveals a heterogeneous pattern, with
predominance of sinus-lining SEVCs (at the parenchyma face
contiguous with some reticulum cells), whereas a few intrasinusal
SEVCs are also positive. Bar 100 µm (in c)
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noted by Wacker (1994), who has interpreted this feature as
suggesting a hematogenous origin of these cells. Immuno-
staining for the macrophage marker CD68 sometimes yields
a finely granular cytoplasmic reaction in SEVCs (not
shown), the significance of which remains to be proven.
Molecular complexes and functional protein interactions
in the complexus adhaerens: hypotheses deduced
from other adhering junctions
The complexus adhaerens represents a remarkable ensem-
ble of junctional molecules that otherwise are known as
constituents of different kinds of junctions (Table 1). In
addition to VE-cadherin and typical adherens junction
plaque proteins, the complexus comprises large amounts
of desmoplakin, generally known as a hallmark protein of
epithelial desmosomes and related cardiomyocytes junc-
tions, as well as claudin-5 and protein JAM-A, i.e., typical
tight junction components. So far, practically no data are
available as to the molecular complexes present in the
complexus adhaerens structures (chemical cross-linking
and immunoprecipitation experiments on micro-dissected
portions of lymph node tissue are currently underway in our
laboratories). On the other hand, hypotheses related to the
possible functions of the major complexus adhaerens
molecules may be deduced from findings in other endothe-
lia, including cell culture and gene abrogation experiments
(for recent reviews on adherens and tight junctions, see
Ebnet et al. 2003; Aijaz et al. 2006; Ebnet 2008; for tight
junctions, see also Burns et al. 2000).
Thus, functional contributions of intact or truncated VE-
cadherin, alone or in interaction with specific junctional
plaque components, in the formation of adhering junction
structures and in the control of endothelial organization,
permeability, and transmigration phenomena have been
repeatedly reported (e.g., Del Maschio et al. 1996; Navarro
Fig. 16 a Double-label LSM of a human lymph node (cryostat
section) for the lymphatic vascular endothelial protein (LYVE-1) (red)
and desmoplakin (green), which colocalize (yellow) in the SEVCs of
the sinus (S); the follicle (F) shows positive staining for desmoplakin
only, reflecting the numerous small desmosomes of the FDCs. Note
also the incomplete match of the two proteins at certain sites of the
SEVC meshwork. b Positive immunostaining of SEVCs, after
histochemistry, in a section through a paraffin-embedded human
pelvic lymph node is also seen for VEGFR-3 (clone 9D9) in an
intermediate sinus (T trabecula), whereas blood vessel (V) endothelium
is essentially negative. c, d On similar sections (intraparotideal lymph
node), podoplanin, as recognized by monoclonal antibody D2–40,
shows highly variable staining of SEVCs. Exceptionally abundant
staining is seen in c, whereas SEVCs in many other areas are negative
or reveal only scarce podoplanin-positive cells, in this case, at the
parenchymatous face of the sinus wall (arrows in d). Note the strong
endothelial staining of a capsular (C capsule) lymph vessel (L in c).
Bars 50 µm (a), 100 µm (b-d)
130 Cell Tissue Res (2009) 335:109–141
et al. 1995, 1998; Hordijk et al. 1999; Corada et al. 1999,
2001; Shaw et al. 2001). Remarkably, from “competition in
situ” experiments by cell transfections with VE-cadherin
cDNA constructs, Jaggi et al. (2002) have concluded that
the affinity of VE-cadherin for other members of the
adherens junction ensemble is so strong that it can displace
N-cadherin from its original structural junction complexes.
Moreover, VE-cadherin has also been shown to occur in
complexes with non-cadherin molecules such as certain
protein kinases, phosphatases, the vascular permeability
factor or vascular endothelial growth factor (VEGF), and
such complexes have been discussed with respect to
functions in the regulation of cell permeability, cell
transmigration, and other “fence and tissue barrier” phe-
nomena, and in specific intra- and intercellular signalling
pathways, in some cases apparently via influences on the
phosphorylation patterns of certain junctional proteins (e.g.,
Allport et al. 1997; Haselton and Heimark 1997; Alexander
et al. 1998; Kevil et al. 1998; Ratcliffe et al. 1999; Johnson-
Léger et al. 2000; Ukropec et al. 2000; Wong et al. 2000;
Ferber et al. 2002; Iyer et al. 2004; Lambeng et al. 2005).
Several molecules, including certain growth factors (e.g.,
VEGF), are known to induce endocytic internalization of
VE-cadherin, also via a clathrin-dependent pathway (e.g.,
Xiao et al. 2003, 2005; Gavard and Gutkind 2006; for
discussion, see also Yap et al. 2007), and obviously, the
greatly enhanced cellular surface of the SEVCs would
provide a gigantic endocytotic capacity.
On the other hand, an influence of certain cadherins and
widespread junction plaque-associated cytoskeletal proteins
such as actin, vinculin, and α-actinin on some tight junction
components and functions has been reported from experi-
ments in rat blood-brain microvessels (e.g., Schulze and
Firth 1993; Lampugnani et al. 2002). In rigorous embryo-
genesis experiments on the role of VE-cadherin in vascular
morphogenesis, the fundamental and manifold importance
of this cadherin has been amply demonstrated (e.g., Vittet et
al. 1997; Carmeliet et al. 1999; Gory-Fauré et al. 1999; for
a recent review, see Ferreri and Vincent 2008; for
endothelial stem cells, see the review of Kubo and Alitalo
2003). In general, however, it is of course questionable
whether and to what extent results obtained with other
kinds of endothelia, i.e., in most cases flat, tightly closed
endothelial cell monolayers, are comparable with or
relevant for those of the complexus adhaerentes, in
particular in the three-dimensionally organized and
branched virgultar system. Here, endothelial permeability
and the control of cell transmigration seem less likely to be
important functions.
Consequently, one might expect that relevant functional
relationships of the SEVC system will be discovered only
in situ, i.e., in lymphatic structures of whole animals (for
example, by alterations of the complexus ensemble after
induction by cell-type-targeted gene abrogation or interfer-
ence, also including the introduction of externally added
substances). Of course, a special problem is presented here
by the abundant desmoplakin in the context of the other
desmosome-specific molecules. Clearly, desmoplakin can
efficiently bind to, and be positioned by, VE-cadherin,
directly or via other junction molecules (e.g., Kowalczyk et
al. 1998; see also Valiron et al. 1996). Desmoplakin is also
known to be of general importance in the embryogenesis of
the vasculature (e.g., Gallicano et al. 2001; Zhou et al.
2004). Moreover, in other kinds of junctions such as in the
area composita of cardiomyocytes in the forming embry-
onic heart, desmoplakin is normally bound to (and
topologically recruited by) plaque-bound plakophilin-2
(Grossmann et al. 2004; for the importance of desmoplakin
in assemblies of adhering and other junctions, see also
Gallicano et al. 2001; Goossens et al. 2007; Koeser et al.
2003; Oxford et al. 2007; Pieperhoff et al. 2008). Thus, the
complexus adhaerens, in which we have not yet detected
any plakophilin-2 (probably small amounts of this gen-
eral and widespread protein occur in nucleoplasmic
regulatory complexes; see, e.g., Mertens et al. 1996, 2001),
presents especially challenging questions as to the binding
partners of desmoplakin and its lymphatic vessel-specific
roles.
Fig. 17 Double-label LS microscopy of a cryostat section through a
human lymph node (T trabecula) immunostained for LYVE-1 (green)
and the adhering junction plaque protein p0071 (red), showing the
presence of this junctional protein in the endothelia of blood vessels of
various calibers (arrows), in contrast to its absence in the SEVCs of an
intermediate sinus (green). Bar 50 µm
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Physiological aspects of SEVCs
During lymph flow through the lymph node sinus, there is
extensive contact of lymph fluid and lymph-borne cells
with the SEVC system, suggesting that this system must
have significant functional importance. The special mor-
phological and molecular features of the SEVC system
should obviously influence the interactions of lymph
components with the SEVC meshwork and the permeability
of the sinus wall structures.
The three-dimensional virgultum formed by intrasinusal
SEVCs is a unique histologic feature in the mammalian
body. Since the fibrillar elements of the extracellular matrix
material spanning the sinus are completely and tightly
covered by SEVCs and their processes, interconnected by
complexus adhaerentes, the reactive surface of sinus cells is
highly expanded, allowing more intense contact of the
lymph and its constituents with the SEVCs. Consequently,
the much enhanced lymphatic endothelial cell surface in the
SEVC system should also enhance the binding and
enrichment of lymphocytes as mediated by cell-cell
receptors such as CLEVER-1 (Irjala et al. 2003). We might
also assume that the jungle of SEVC processes in the lymph
node sinus reduces the flow speed of the percolating cells,
particles, and molecules, thereby facilitating the recogni-
tion, monitoring, endocytosis, and further processing of the
incoming components of the lymphatic fluid. Certainly, this
also supports the filter function of lymph nodes exerted by
the phagocytic activity of sinus macrophages, which filter
particulate material out of the lymph (for a review on
scavenger function uptake by endothelial cells, see
Smedsrød 2004). In rat lymph nodes, Sainte-Marie and
Peng (1986) have specifically shown that lymph-carried
fluorescence-labeled antigen proteins (albumin, Igs) are
retained in certain parts of the subcapsular sinus, where
they are associated with either cells lining the inner sinus
wall or intrasinusal SEVCs.
In these experiments, certain fluorescently labeled anti-
gens have been seen later to enter the parenchyma, along
reticular fibers (Sainte-Marie and Peng 1986), pointing to
the second major role of the SEVC system, i.e., the
permeability of the parenchyma-bordering sinus walls with
their lining layer of SEVCs, which is of utmost importance
for the immunologic functions of lymph nodes. Obviously,
lymph-borne diffusible antigens and particles and antigen-
presenting cells must be able to reach the parenchyma, and
T-lymphocytes must be able to leave the parenchyma to
reach the sinus lymph system. The existence of gaps or
pores in the SEVC layer lining the parenchymatous sides of
the sinus seems now established (for references, see above),
and processes of FRCs and in particular macrophages have
been described to protrude into these intercellular spaces
(e.g., Sakuma et al. 1981; Ushiki et al. 1995); such cells
may well migrate and pass through the sinus wall. Several
recent elegant function-oriented studies in mice have indeed
shown that sialoadhesin (CD169, MOMA-1)-containing
macrophages form cell processes that protrude between
SEVCs and that capture immune complexes or viral
particles from the lymph and deliver such material to B-
cells in the parenchyma (Phan et al. 2007; Junt et al. 2007;
Martinez-Pomares and Gordon 2007). However, in spite of
the presence of pores or gaps in the SEVC layer lining the
parenchymatous walls of sinus, injection experiments in
mice and rats have also indicated the existence of a
functional barrier restricting the percolation of soluble
lymph-borne molecules of >70 kDa from the subcapsular
sinus into the lymph node cortex (Gretz et al. 2000).
Recently, Pfeiffer et al. (2008) have demonstrated that
lymph-borne fluorescently labeled, large dextran (high-
molecular weight, 2000 kDa) is strictly retained in the
subcapsular and medullary sinus and does not enter the
parenchyma. However, small molecules and particles
(<70 kDa, e.g., 10-kDa dextran) can apparently penetrate
the sinus walls and gain access to the cortex (Gretz et al.
2000) and to the paracortex and medullary regions of the
parenchyma (Pfeiffer et al. 2008). How can the presence of
such structural gaps or pores in the sinus-lining SEVC layer
be compatible with its barrier function to large molecules
and to particles? What functional role do the SEVC
junctions, notably the complexus adhaerentes with their
tight-junction-type components, play in the control of the
sinus wall permeability? These questions remain to be
answered.
Of course, sinus walls also need to allow the passage of
various types of cells between the lymph and the
parenchyma, in both directions. For example, recirculating
T-lymphocytes migrate from high endothelial venules into
intermediate sinus, thereby crossing the sinus wall. Specif-
ically, lymphocyte transmigration across the sinus-lining
cell layer appears to be an active process during which
these cells assume a distorted hourglass morphology (for
references, see Gretz et al. 1997; Johnson-Léger et al.
2000). Recently, sphingosine 1-phosphate (S1P) receptors
located on endothelial cells (SEVCs) lining the medullary
sinus have been shown to control the passage of T-
lymphocytes from the medullary cords through pores in
the sinus wall into the sinus lumen, with transient
deactivation of the receptor complexes opening these gates
(Wei et al. 2005). Singer et al. (2005) reported that
treatment of mice with the immunosuppressant FTY720, a
S1P receptor agonist, resulted in an enhanced production of
the junctional molecules CD31, β-catenin, and protein
ZO-1, all colocalized in intercellular junctions of lymphatic
endothelial cells (SEVCs) of subcapsular sinus, suggestive
of a special regulatory system in the subcapsular sinus-
lining cell barrier (Singer et al. 2005). Apparently, accord-
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ing to the immunofluorescence data shown, this process
was also accompanied by hyperplasia of the SEVCs.
Furthermore, dendritic cells (DCs) floating in the lymph
are well-known to be able to penetrate the sinus wall
actively, including the lining SEVC layer, and to find their
way into the parenchyma (for references, see Willard-Mack
2006). SEVCs may also have adhesive properties by which
macrophages can be trapped in the meshes of the luminal
network of the intrasinusal SEVC system and apparently
stick to the surface of these cells (Compton and Raviola
1985); obvious candidates for such adhesive functions
include CD31 and LYVE-1.
Fibroblastoid and sinus endothelial/virgultar cells of lymph
nodes: pathological changes and autochthonous tumor
formations
Non-tumorous changes
Whereas lymph nodes play a major role in human
pathology, relatively little is known about the pathology
of SEVCs. Non-neoplastic changes involving the sinus
include sinus catarrh and sinus histiocytosis. Sinus
catarrh is a reactive condition that might be attributable
to bacterial infections and is characterized by dilated
sinus spaces, containing lymph fluid together with
lymphocytes and other leukocytes (Fig. 18a). In such
cases, hyperplasia of intrasinusal SEVCs, here outlined
by the SEVC marker CD31 (Fig. 18b), is noted, as has
also previously been described by Wacker (1994) using
Ki-M9 as a marker.
Sinus histiocytosis, another reactive lymph node change
that can develop in the draining area of chronic inflamma-
tions or tumors is characterized by expanded sinus filled
with large histiocytes (“swollen macrophages”). Figure 18c
shows the case of a particularly pronounced sinus histiocy-
tosis with resorptive vacuolization of the sinus histiocytes.
Whereas in routine light microscopy, SEVCs are difficult to
recognize on the background of the prominent histiocytes
(Fig. 18c), immunohistochemistry (here using desmoplakin
as a SEVC marker) clearly highlights these cells, which
again are hyperplastic and form an extended network
spanning between the sinus histiocytes (Fig. 18d; cf.
Schmelz et al. 1994). Since SEVCs appear to express
VEGFR-3 (Fig. 16b), its ligand VEGF-C, which can be
synthesized by tumors (Jackson et al. 2001), might be
involved in the induction of SEVC hyperplasia. Increased
numbers of SEVCs with prominent connexin 43 have been
observed in lymph nodes involved in Langerhans cell
histiocytosis and in malignant lymphomas (Krenács and
Rosendaal 1995). In contrast, in monocytoid B-cell reaction
occurring in the context of Piringer’s lymphadenitis,
decreased numbers and interrupted arrangements of SEVCs
have been recognized by monoclonal antibody Ki-M9
(Wacker 1994).
Tumors
Although the lymph node is generally known as a major
site of lymphoid neoplasms and of metastatic tumor
spread and growth (for a review, see Chambers et al.
2002), we should not overlook the existence of some
specific tumors directly derived from non-lymphatic
architectural cell types of the lymph node. All major
reticulum-forming cell types seem to be able to give rise to
certain tumors, which appear to maintain the synthesis of
some cell-type-specific proteins and thus can be diagnos-
tically characterized and related to the cell type of origin.
As is frequently stated, the autochthonous tumors of the
lymph node present a severe diagnostic problem, primarily
because of the lack of reliable morphological properties.
Thus, molecular markers should provide a highly desired
armamentarium of potential value in the diagnoses of such
tumors.
FDC tumors
FDCs, which form the three-dimensional multiform
branching meshwork of the reticulum system of lymph
follicles, including those of the lymph nodes, have been
known for more than two decades to be able to transform
into a special tumor subtype, classified as FDC tumors or
sarcomas (Monda et al. 1986). Ultrastructurally, these
tumors exhibit dendritic cell processes connected by
scattered small but mature desmosomes. Immunohisto-
chemically, FDC sarcomas are characterized by positive
reactions for vimentin and desmoplakin and other desmo-
somal components, and with the advent of appropriate
molecular markers, the frequency of diagnoses of these
tumors has markedly increased (e.g., Perez-Ordonez et al.
1996; Chan et al. 1997; Chan et al. 2000; Sun et al. 2003;
for a review, see Fonseca et al. 1998; see therein for
further references). However, the molecular characteriza-
tion of such tumors of mesenchymal cell origin, notably in
lymph nodes, spleen, and dispersed lymphatic follicles, is
still very much in its infancy, as these tumors represent
typical examples in which morphological criteria or
“broad”, i.e. non-selective, markers are simply not
sufficient for a diagnosis justifiable on cell biological
grounds (for discussion, see also S.W. Weiss et al. 1989;
L.M. Weiss et al. 1990; Kawachi et al. 2002).
IDC tumors
These extremely rare neoplasms exhibit phenotypic features
similar to those of IDCs, antigen-presenting cells of the T-
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cell system (Jaffe et al. 2001). Like their normal counter-
parts, these interdigitating dendritic cell sarcomas/tumors
are characterized by S-100 protein. Ultrastructurally, they
show interdigitating cell processes, but desmosomes are not
present. Data on junctional markers are to our knowledge
not yet available.
FRC tumors
FRCs outside of follicles are not well defined with respect
to cell and molecular biological markers. Nevertheless, they
appear to represent another kind of architectural and
accessory cell that can give rise to special tumors, including
metastatic tumors, originating in lymph nodes or in the
spleen (for cases and detailed discussion, see Andriko et al.
1998; Martel et al. 2003).
CIRC tumors
CIRCs (Franke and Moll 1987; Gould et al. 1995; see also
Doglioni et al. 1990) have been characterized as a subtype of
fibroblastoid interstitial cells, i.e., FRCs that are located
between the follicles and the sinus and that constitute the
major cellular framework of the lymph node parenchyma.
CIRCs have been identified as the cell type of origin of a
special group of tumors, usually referred to as CIRC tumors
or CIRC sarcomas. Following their first description by Gould
et al. (1990), a series of publications have confirmed the
existence of this tumor group and have added further valuable
biological and clinical observations (e.g., Gould et al. 1995;
Chan et al. 2000; Lucioni et al. 2003; Schuerfeld et al. 2003;
Dong et al. 2008). In general, cytokeratin positivity,
especially for keratins 8 and 18, and desmoplakin-negative
Fig. 18 Altered distribution patterns of SEVCs in reactive patholog-
ical changes of human lymph nodes. Sinus catarrh (a, b mesenterial
lymph node) is characterized by distended sinus with some floating
cells and also presents a SEVC hyperplasia (a H&E staining; b CD31
immunostaining, clone JC70A). Note also the nearly complete CD31
staining of the cell surfaces of both intrasinusal SEVCs and the sinus-
lining SEVC layer. A case of resorptive sinus histiocytosis (c, d
cervical lymph node) exhibits abundant sinus histiocytes with
vacuolated cytoplasm (c H&E staining); the hyperplastic SEVCs are
clearly visible only after specific immunostaining, in this case, by a
desmoplakin antibody (d clone DP-2.17). Bar 100 µm
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reactions are at present the most valuable immunohistochem-
ical characteristics of these genuine lymph node sarcomas,
which include some rather aggressive forms.
SEVC-derived sarcomas
Impressed by the intense LYVE-1 immunostaining reaction
in a single case of a dendritic-cell-like tumor, Krokowski et
al. (2008) have recently proposed the existence of another
distinct subtype of a dendritic lymph node cell sarcoma,
which they have termed “sarcoma of sinus-lining cells”.
The case described was characterized by the presence of
CD31 and LYVE-1. Previously, Wacker (1994) had
described a case of reticulosarcoma (reticulosis) of sinus
wall cells. The series of molecular markers of SEVCs,
notably those of the complexus adhaerens presented in this
review, should now provide useful diagnostic reagents to
identify and define this category of potential SEVC tumors.
Conclusions and perspectives
The molecular characterization of the morphological sub-
forms of lining and intraluminal cells of the lymph node
sinus now obviously provides sufficient data and markers to
identify these cells, to subsume them under a collective
term as “sinus endothelial/virgultar cells” (SEVCs), and to
lay to rest the various hypotheses of a non-endothelial (e.g.,
monocytic, FRC) nature and origin of these cells (for
controversial hypotheses and arguments, see Wacker 1994;
Wacker et al. 1997; Gretz et al. 1997; Welsch et al. 1997;
Crivellato and Mallardi 1998; Kaldjian et al. 2001; Willard-
Mack 2006; and references cited therein; for a “historic”
discussion, see also Raviola 1975). Clearly, the presence of
an impressive ensemble of true endothelial differentiation
markers establishes their endothelial or endothelium-derived
nature and origin. The absence of any keratins and true
desmosomes also apparently excludes a derivation from or
relationship with FRCs (including CIRCs) or FDCs.
Our conclusion that the morphologically highly different
lining and luminal meshwork cells of the SEVC system of
the lymph node sinus are indeed endothelial and endothe-
lial-cell-derived morphotypes is strongly supported by the
findings that they constitutively contain characteristic
vascular and lymphatic endothelial hallmark molecules
such as factor-VIII-related antigen, CD31, VE-cadherin,
claudin-5, JAM-A, LYVE-1, and VEGFR-3, together with
the “special” component, desmoplakin. A similar though
not identical combination of molecular markers (e.g.,
factor-VIII-related antigen, CD31, VE-cadherin, claudin-5,
JAM-A, LYVE-1, VEGFR-3, and desmoplakin, but in
addition ESAM-1 and high levels of podoplanin) is present
in various other parts of the lymphatic vessel system,
including several lymphatic capillaries (e.g., Schmelz et al.
1994; Baluk et al. 2007; Pfeiffer et al. 2008). Thus, despite
being divided into two major morphotypes, SEVCs can be
regarded as one distinct cell type, specifically as a special
subtype of endothelial cells related to, but not completely
identical with, lymphatic vessel endothelium. Therefore, as
a corollary, one might consider the SEVC system of the
lymph node sinus as a local and specific modification of the
general lymphatic vasculature system.
An impressive morphological and molecular character-
istic of the SEVC system is their frequent, variously sized,
complex cell-cell junctions of a unique type, the complexus
adhaerens, which combines typical molecules of three
different types of cell-cell junctions, i.e., the transmembrane
glycoprotein VE-cadherin, α- and β-catenin, p120 catenin,
and afadin of adherens junctions, desmoplakin and plako-
globin of desmosomes, and the tight-junction-characteristic
transmembrane proteins, claudin-5 and JAM-A, together
with protein ZO-1, a plaque protein generally common to
tight, adherens, and gap junctions. We have also identified
and characterized an extended and tight ensheathing of the
sinusal trabecular tissue and the extracellular reticular
fibers, notably those with paracrystalline collagen bundles,
by thin cytoplasmic processes of SEVCs, which again are
“stitched” together with series of complexus adhaerentes.
On the other hand, we have observed some impressive
differences between the complexus adhaerens of the SEVC
system and the adherens junctions of other endothelia, such
as the abundance, in the former, of desmoplakin and the
absence of appreciable amounts of the transmembrane
glycoprotein N-cadherin and the plaque protein, p0071.
We hypothesize that the SEVCs and their frequent and cell-
type-specific complexus adhaerens junctions with their
unique and complex ensemble of junctional molecules
provide the architectural basis for major functions of the
lymph node sinus; we have discussed above the composi-
tional differences of the endothelial organisation in various
parts of the lymph node in comparison with other parts of
the vascular system.
Indeed, lymphocytes, monocytes, notably macrophages
and mast cells, plasma cells, and polymorphonuclear
leukocytes can all be seen within the sinus confinements,
but they do not markedly contribute to the basic sinus
architecture. However, as suggested by the expanded
surface of the SEVC system and the presence of adhesive
surface molecules on SEVCs, all these cells probably
interact in different ways with the SEVC system, as most
probably do malignant cells from solid tumors that have
found their way into lymph node sinus during early
lymphatic dissemination. The elucidation of the specific
mechanisms of these interactions will be extremely impor-
tant in future studies. The molecular markers and inter-
actions demonstrated have enhanced our understanding of
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lymph node functions and should provide a better basis for
future research in immunology and in pathology, including
improved detection and classification of autochthonous
lymph node tumors and deeper insight into the mechanisms
of early stages of lymph node metastases.
Acknowledgements We thank Renate Baumann, Sabine Koch, and
Viktoria Morokina (Marburg) for expert technical help, and Eva
Gundel (Heidelberg) for careful typing of the manuscript.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
Ahrens T, Lambert M, Pertz O, Sasaki T, Schulthess T, Mege RM,
Timpl R, Engel J (2003) Homoassociation of VE-cadherin
follows a mechanism common to “classical” cadherins. J Mol
Biol 325:733–742
Aijaz S, Balda MS, Matter K (2006) Tight junctions: molecular
architecture and function. Int Rev Cytol 248:261–298
Akat K, Bleck CK, Lee YM, Haselmann-Weiss U, Kartenbeck J
(2008) Characterization of a novel type of adherens junction in
meningiomas and the derived cell line HBL-52. Cell Tissue Res
331:401–412
Akazaki K (1953) Tumors of the reticulo-endothelial system. Acta
Pathol Jpn 3:24–43
Alexander JS, Jackson SA, Chaney E, Kevil CG, Haselton FR (1998)
The role of cadherin endocytosis in endothelial barrier regulation:
involvement of protein kinase C and actin-cadherin interactions.
Inflammation 22:419–433
Al-Rawi MA, Mansel RE, Jiang WG (2005) Lymphangiogenesis and
its role in cancer. Histol Histopathol 20:283–298
Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in
development and human disease. Nature 438:946–953
Allport JR, Ding H, Collins T, Gerritsen ME, Luscinskas FW (1997)
Endothelial-dependent mechanisms regulate leukocyte transmi-
gration: a process involving the proteasome and disruption of the
vascular endothelial-cadherin complex at endothelial cell-to-cell
junctions. J Exp Med 186:517–527
Anastasiadis PZ, Reynolds AB (2000) The p120 catenin family:
complex roles in adhesion, signaling and cancer. J Cell Sci
113:1319–1334
Andrian UH von, Mempel TR (2003) Homing and cellular traffic in
lymph nodes. Nat Rev Immunol 3:867–878
Andriko JW, Kaldjian EP, Tsokos M, Abbondanzo SL, Jaffe ES
(1998) Reticulum cell neoplasms of lymph nodes: a clinicopath-
ologic study of 11 cases with recognition of a new subtype
derived from fibroblastic reticular cells. Am J Surg Pathol
22:1048–1058
Aschoff L (1924) Das reticulo-endotheliale System. Ergeb Inn Med
Kinderheilkd 26:1–118
Aurrand-Lions M, Duncan L, Ballestrem C, Imhof BA (2001) JAM-2,
a novel immunoglobulin superfamily molecule, expressed by
endothelial and lymphatic cells. J Biol Chem 276:2733–2741
Bajénoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N,
Germain RN (2006) Stromal cell networks regulate lymphocyte
entry, migration, and territoriality in lymph nodes. Immunity
25:989–1001
Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S,
Vestweber D, Corada M, Molendini C, Dejana E, McDonald DM
(2007) Functionally specialized junctions between endothelial
cells of lymphatic vessels. J Exp Med 204:2349–2362
Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M,
Jackson DG (1999) LYVE-1, a new homologue of the CD44
glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell
Biol 144:789–801
Birk DE, Trelstad RL (1986) Extracellular compartments in tendon
morphogenesis: collagen fibril, bundle, and macroaggregate
formation. J Cell Biol 103:231–240
Borrmann CM, Grund C, Kuhn C, Hofmann I, Pieperhoff S, Franke
WW (2006) The area composita of adhering junctions connecting
heart muscle cells of vertebrates. II. Colocalizations of desmo-
somal and fascia adhaerens molecules in the intercalated disk.
Eur J Cell Biol 85:469–485
Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G,
Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K,
Kerjaschki D (1999) Angiosarcomas express mixed endothelial
phenotypes of blood and lymphatic capillaries: podoplanin as a
specific marker for lymphatic endothelium. Am J Pathol
154:385–394
Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay
J, Introna M, Gulino D, Lampugnani MG, Dejana E (1995)
Functional properties of human vascular endothelial cadherin
(7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler
Thromb Vasc Biol 15:1229–1239
Burgio VL, Zupo S, Roncella S, Zocchi M, Ruco LP, Baroni CD
(1994) Characterization of EN4 monoclonal antibody: a reagent
with CD31 specificity. Clin Exp Immunol 96:170–176
Burns AR, Bowden RA, MacDonell SD, Walker DC, Odebunmi TO,
Donnachie EM, Simon SI, Entman ML, Smith CW (2000)
Analysis of tight junctions during neutrophil transendothelial
migration. J Cell Sci 113:45–57
Calkins CC, Hoepner BL, Law CM, Novak MR, Setzer SV, Hatzfeld
M, Kowalczyk AP (2003) The armadillo family protein p0071 is
a VE-cadherin- and desmoplakin-binding protein. J Biol Chem
278:1774–1783
Canty EG, Lu Y, Meadows RS, Shaw MK, Holmes DF, Kadler KE
(2004) Coalignment of plasma membrane channels and protru-
sions (fibripositors) specifies the parallelism of tendon. J Cell
Biol 165:553–563
Canty EG, Starborg T, Lu Y, Humphries SM, Holmes DF, Meadows
RS, Huffman A, O’Toole ET, Kadler KE (2006) Actin filaments
are required for fibripositor-mediated collagen fibril alignment in
tendon. J Biol Chem 281:38592–38598
Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V,
Bono F, Balconi G, Spagnuolo R, Oostuyse B, Dewerchin M,
Zanetti A, Angellilo A, Mattot V, Nuyens D, Lutgens E, Clotman
F, Ruiter MC de, Gittenberger-de Groot A, Poelmann R, Lupu F,
Herbert JM, Collen D, Dejana E (1999) Targeted deficiency or
cytosolic truncation of the VE-cadherin gene in mice impairs
VEGF-mediated endothelial survival and angiogenesis. Cell
98:147–157
Cattelino A, Liebner S, Gallini R, Zanetti A, Balconi G, Corsi A,
Bianco P, Wolburg H, Moore R, Oreda B, Kemler R, Dejana E
(2003) The conditional inactivation of the beta-catenin gene in
endothelial cells causes a defective vascular pattern and increased
vascular fragility. J Cell Biol 162:1111–1122
Caveda L, Martin-Padura I, Navarro P, Breviario F, Corada M, Gulino
D, Lampugnani MG, Dejana E (1996) Inhibition of cultured cell
growth by vascular endothelial cadherin (cadherin-5/VE-cadherin).
J Clin Invest 98:886–893
Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and
growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–
572
136 Cell Tissue Res (2009) 335:109–141
Chan AC, Serrano-Olmo J, Erlandson RA, Rosai J (2000) Cytokeratin-
positive malignant tumors with reticulum cell morphology: a
subtype of fibroblastic reticulum cell neoplasm? Am J Surg Pathol
24:107–116
Chan JK, Fletcher CD, Nayler SJ, Cooper K (1997) Follicular
dendritic cell sarcoma. Clinicopathologic analysis of 17 cases
suggesting a malignant potential higher than currently recog-
nized. Cancer 79:294–313
Chikwava K, Jaffe R (2004) Langerin (CD207) staining in normal
pediatric tissues, reactive lymph nodes, and childhood histiocytic
disorders. Pediatr Dev Pathol 7:607–614
Compton CC, Raviola E (1985) Structure of the sinus-lining cells in
the popliteal lymph node of the rabbit. Anat Rec 212:408–423
Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus
M, Lampugnani MG, Martin-Padura I, Stoppacciaro A, Ruco L,
McDonald DM, Ward PA, Dejana E (1999) Vascular endothelial-
cadherin is an important determinant of microvascular integrity in
vivo. Proc Natl Acad Sci USA 96:9815–9820
Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R,
Muller WA, Hicklin DJ, Bohlen P, Dejana E (2001) Monoclonal
antibodies directed to different regions of vascular endothelial
cadherin extracellular domain affect adhesion and clustering of the
protein and modulate endothelial permeability. Blood 97:1679–1684
Cowin P, Kapprell HP, Franke WW, Tamkun J, Hynes RO (1986)
Plakoglobin: a protein common to different kinds of intercellular
adhering junctions. Cell 46:1063–1073
Crivellato E, Mallardi F (1998) The sinus endothelial cell architecture
in the mouse lymph node. Structural peculiarities and close
correlation with the fibroblastic reticular cells. J Submicrosc
Cytol Pathol 30:495–502
Danilov SM, Muzykantov VR, Martynov AV, Atochina EN, Sakharov
IY, Trakht IN, Smirnov VN (1991) Lung is the target organ for a
monoclonal antibody to angiotensin-converting enzyme. Lab
Invest 64:118–124
Dejana E (1996) Endothelial adherens junctions: implications in the
control of vascular permeability and angiogenesis. J Clin Invest
98:1949–1953
Dejana E (2004) Endothelial cell-cell junctions: happy together. Nat
Rev Mol Cell Biol 5:261–270
Dejana E, Bazzoni G, Lampugnani MG (1999) Vascular endothelial
(VE)-cadherin: only an intercellular glue? Exp Cell Res 252:13–19
Dejana E, Lampugnani MG, Martinez-Estrada O, Bazzoni G (2000)
The molecular organization of endothelial junctions and their
functional role in vascular morphogenesis and permeability. Int J
Dev Biol 44:743–748
Del Maschio A, Zanetti A, Corada M, Rival Y, Ruco L, Lampugnani
MG, Dejana E (1996) Polymorphonuclear leukocyte adhesion
triggers the disorganization of endothelial cell-to-cell adherens
junctions. J Cell Biol 135:497–510
Doglioni C, Dell’Orto P, Zanetti G, Iuzzolino P, Coggi G, Viale G
(1990) Cytokeratin-immunoreactive cells of human lymph nodes
and spleen in normal and pathological conditions. An immuno-
cytochemical study. Virchows Arch [A] 416:479–490
Dong YC, Wu B, Sheng Z, Wang JD, Zhou HB, Zhou XJ (2008)
Cytokeratin-positive interstitial reticulum cell tumors of lymph
nodes: a case report and review of literature. Chin Med J (Engl)
121:658–663
Drinker CK, Wislocki GB, Field ME (1933) The structure of the
sinuses of the lymph nodes. Anat Rec 56:261–273
Drinker CK, Field ME, Ward HK (1934) The filtering capacitiy of
lymph nodes. J Exp Med 59:393–405
Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for
angiogenesis: evidence and potential applications. FASEB J
17:984–992
Düllmann J, Van Damme EJ, Peumans WJ, Ziesenitz M, Schumacher
U (2002) Lectin histochemistry of the rat lymph node: visual-
isation of stroma, blood vessels, sinuses, and macrophages. A
contribution to the concept of an immune accessory role of sinus-
lining endothelia. Acta Histochem 104:77–83
Ebata N, Nodasaka Y, Sawa Y, Yamaoka Y, Makino S, Totsuka Y,
Yoshida S (2001a) Desmoplakin as a specific marker of lymphatic
vessels. Microvasc Res 61:40–48
Ebata N, Sawa Y, Nodasaka Y, Yamaoka Y, Yoshida S, Totsuka Y
(2001b) Immunoelectron microscopic study of PECAM-1 ex-
pression on lymphatic endothelium of the human tongue. Tissue
Cell 33:211–218
Ebnet K (2008) Organization of multiprotein complexes at cell-cell
junctions. Histochem Cell Biol 130:1–20
Ebnet K, Aurrand-Lions M, Kuhn A, Kiefer F, Butz S, Zander K,
Meyer zu Brickwedde MK, Suzuki A, Imhof BA, Vestweber D
(2003) The junctional adhesion molecule (JAM) family members
JAM-2 and JAM-3 associate with the cell polarity protein PAR-3:
a possible role for JAMs in endothelial cell polarity. J Cell Sci
116:3879–3891
Farr AG, Cho Y, De Bruyn PP (1980) The structure of the sinus wall
of the lymph node relative to its endocytic properties and
transmural cell passage. Am J Anat 157:265–284
Ferber A, Yaen C, Sarmiento E, Martinez J (2002) An octapeptide in
the juxtamembrane domain of VE-cadherin is important for
p120ctn binding and cell proliferation. Exp Cell Res 274:35–44
Ferreri DM, Vincent PA (2008) Signaling to and through endothelial
adherens junction. In: LaFlamme SE, Kowalczyk AP (eds) Cell
junctions. Adhesion, development, and disease. WILEY-VCH,
Weinheim, pp 169–195
Fiedler U, Christian S, Koidl S, Kerjaschki D, Emmett MS, Bates DO,
Christofori G, Augustin HG (2006) The sialomucin CD34 is a
marker of lymphatic endothelial cells in human tumors. Am J
Pathol 168:1045–1053
Fonseca R, Yamakawa M, Nakamura S, Heerde P van, Miettinen M,
Shek TW, Myhre JO, Rousselet MC, Tefferi A (1998) Follicular
dendritic cell sarcoma and interdigitating reticulum cell sarcoma:
a review. Am J Hematol 59:161–167
Forkert PG, Thliveris JA, Bertalanffy FD (1977) Structure of sinuses
in the human lymph node. Cell Tissue Res 183:115–130
Franke WW, Moll R (1987) Cytoskeletal components of lymphoid
organs. I. Synthesis of cytokeratins 8 and 18 and desmin in
subpopulations of extrafollicular reticulum cells of human lymph
nodes, tonsils, and spleen. Differentiation 36:145–163
Franke WW, Schmid E, Osborn M, Weber K (1979) Intermediate-sized
filaments of human endothelial cells. J Cell Biol 81:570–580
Franke WW, Schmid E, Grund C, Müller H, Engelbrecht I, Moll R,
Stadler J, Jarasch E-D (1981) Antibodies to high molecular
weight polypeptides of desmosomes: specific localization of a
class of junctional proteins in cells and tissues. Differentiation
20:217–241
Franke WW, Moll R, Schiller DL, Schmid E, Kartenbeck J, Müller H
(1982) Desmoplakins of epithelial and myocardial desmosomes
are immunologically and biochemically related. Differentiation
23:115–127
Franke WW, Kapprell HP, Cowin P (1987) Immunolocalization of
plakoglobin in endothelial junctions: identification as a special
type of zonulae adhaerentes. Biol Cell 59:205–218
Franke WW, Cowin P, Grund C, Kuhn C, Kapprell HP (1988) The
endothelial junction. The plaque and its components. In:
Simionescu N, Simionescu M (eds) Endothelial cell biology in
health and disease. Plenum, New York, pp 147–166
Franke WW, Goldschmidt MD, Zimbelmann R, Mueller HM, Schiller
DL, Cowin P (1989a) Molecular cloning and amino acid
sequence of human plakoglobin, the common junctional plaque
protein. Proc Natl Acad Sci USA 86:4027–4031
Franke WW, Jahn L, Knapp AC (1989b) Cytokeratins and desmo-
somal proteins in certain epithelioid and nonepithelial cells. In:
Cell Tissue Res (2009) 335:109–141 137
Osborn M, Weber K (eds) Cytoskeletal proteins in tumor
diagnosis. Current communications in molecular biology. Cold
Spring Harbour Laboratory, Cold Spring Harbor, pp 151–172
Franke WW, Koch PJ, Schäfer S, Heid HW, Troyanovsky SM, Moll I,
Moll R (1994) The desmosome and the syndesmos: cell junctions
in normal development and in malignancy. Princess Takamatsu
Symp 24:14–27
Franke WW, Borrmann CM, Grund C, Pieperhoff S (2006) The area
composita of adhering junctions connecting heart muscle cells of
vertebrates. I. Molecular definition in intercalated disks of
cardiomyocytes by immunoelectron microscopy of desmosomal
proteins. Eur J Cell Biol 85:69–82
Fujita T, Miyoshi M, Murakami T (1972) Scanning electron
microscope observation of the dog mesenteric lymph node. Z
Zellforsch Mikrosk Anat 133:147–162
Gallicano GI, Bauer C, Fuchs E (2001) Rescuing desmoplakin
function in extra-embryonic ectoderm reveals the importance of
this protein in embryonic heart, neuroepithelium, skin and
vasculature. Development 128:929–941
Gavard J, Gutkind JS (2006) VEGF controls endothelial-cell perme-
ability by promoting the beta-arrestin-dependent endocytosis of
VE-cadherin. Nat Cell Biol 8:1223–1234
Goossens S, Janssens B, Bonne S, De Rycke R, Braet F, Hengel J van,
Roy F van (2007) A unique and specific interaction between
alphaT-catenin and plakophilin-2 in the area composita, the
mixed-type junctional structure of cardiac intercalated discs. J
Cell Sci 120:2126–2136
Gory-Fauré S, Prandini MH, Pointu H, Roullot V, Pignot-Paintrand I,
Vernet M, Huber P (1999) Role of vascular endothelial-cadherin
in vascular morphogenesis. Development 126:2093–2102
Gould VE, Warren WH, Faber LP, Kuhn C, Franke WW (1990)
Malignant cells of epithelial phenotype limited to thoracic lymph
nodes. Eur J Cancer 26:1121–1126
Gould VE, Bloom KJ, Franke WW, Warren WH, Moll R (1995)
Increased numbers of cytokeratin-positive interstitial reticulum
cells (CIRC) in reactive, inflammatory and neoplastic lymphade-
nopathies: hyperplasia or induced expression? Virchows Arch
425:617–629
Gretz JE, Anderson AO, Shaw S (1997) Cords, channels, corridors
and conduits: critical architectural elements facilitating cell
interactions in the lymph node cortex. Immunol Rev 156:11–
24
Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S (2000)
Lymph-borne chemokines and other low molecular weight
molecules reach high endothelial venules via specialized conduits
while a functional barrier limits access to the lymphocyte micro-
environments in lymph node cortex. J Exp Med 192:1425–1440
Grossmann KS, Grund C, Huelsken J, Behrend M, Erdmann B,
Franke WW, Birchmeier W (2004) Requirement of plakophilin 2
for heart morphogenesis and cardiac junction formation. J Cell
Biol 167:149–160
Hämmerling B (2004) Molekulare Charakterisierung der verschiede-
nen Zell-Zell-Verbindungsstrukturen (“Junctions”) in Lymphkno-
ten höherer Säugetiere. [Molecular characterization of the diverse
cell-cell-junctions in lymph nodes of higher mammals]. M.D.
Thesis. Faculty of Medicine, Ruprechts-Karls-University, Heidel-
berg, Germany
Hämmerling B, Grund C, Boda-Heggemann J, Moll R, Franke WW
(2006) The complexus adhaerens of mammalian lymphatic
endothelia revisited: a junction even more complex than hitherto
thought. Cell Tissue Res 324:55–67
Haselton FR, Heimark RL (1997) Role of cadherins 5 and 13 in the
aortic endothelial barrier. J Cell Physiol 171:243–251
Hatzfeld M (2005) The p120 family of cell adhesion molecules. Eur J
Cell Biol 84:205–214
Hatzfeld M (2007) Plakophilins: multifunctional proteins or just
regulators of desmosomal adhesion? Biochim Biophys Acta
1773:69–77
Hatzfeld M, Nachtsheim C (1996) Cloning and characterization of a
new armadillo family member, p0071, associated with the
junctional plaque: evidence for a subfamily of closely related
proteins. J Cell Sci 109:2767–2778
Hayakawa M, Kobayashi M, Hoshino T (1990) Microfibrils: a
constitutive component of reticular fibers in the mouse lymph
node. Cell Tissue Res 262:199–201
Hayes H, Kossmann E, Wilson E, Meininger C, Zawieja D (2003)
Development and characterization of endothelial cells from rat
microlymphatics. Lymphat Res Biol 1:101–119
Heid HW, Schmidt A, Zimbelmann R, Schäfer S, Winter-Simanowski
S, Stumpp S, Keith M, Figge U, Schnölzer M, Franke WW
(1994) Cell type-specific desmosomal plaque proteins of the
plakoglobin family: plakophilin 1 (band 6 protein). Differentiation
58:113–131
Hinz B, Pittet P, Smith-Clerc J, Chaponnier C, Meister JJ (2004)
Myofibroblast development is characterized by specific cell-cell
adherens junctions. Mol Biol Cell 15:4310–4320
Hofmann I, Schlechter T, Kuhn C, Hergt M, Franke WW (2008)
Protein p0071, an armadillo plaque protein that characterizes a
specific subtype of adherens junctions and their functions. J Cell
Sci, in press
Hordijk PL, Anthony E, Mul FP, Rientsma R, Oomen LC, Roos D
(1999) Vascular-endothelial-cadherin modulates endothelial
monolayer permeability. J Cell Sci 112:1915–1923
Horikawa K, Radice G, Takeichi M, Chisaka O (1999) Adhesive
subdivisions intrinsic to the epithelial somites. Dev Biol
215:182–189
Irjala H, Elima K, Johansson EL, Merinen M, Kontula K, Alanen K,
Grenman R, Salmi M, Jalkanen S (2003) The same endothelial
receptor controls lymphocyte traffic both in vascular and
lymphatic vessels. Eur J Immunol 33:815–824
Iyer S, Ferreri DM, DeCocco NC, Minnear FL, Vincent PA (2004)
VE-cadherin-p120 interaction is required for maintenance of
endothelial barrier function. Am J Physiol Lung Cell Mol Physiol
286:L1143–L1153
Jackson DE (2003) The unfolding tale of PECAM-1. FEBS Lett
540:7–14
Jackson DG, Prevo R, Clasper S, Banerji S (2001) LYVE-1, the
lymphatic system and tumor lymphangiogenesis. Trends Immunol
22:317–321
Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Pathology and
genetics of tumours of haematopoietic and lymphoid tissues.
World Health Organization Classification of Tumours. IARC
Press, Lyon
Jaggi M, Wheelock MJ, Johnson KR (2002) Differential displacement
of classical cadherins by VE-cadherin. Cell Commun Adhes
9:103–115
Johnson-Léger C, Aurrand-Lions M, Imhof BA (2000) The parting of
the endothelium: miracle, or simply a junctional affair? J Cell Sci
113:921–933
Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, Boes M,
Fink K, Henrickson SE, Shayakhmetov DM, Di Paolo NC,
Rooijen N van, Mempel TR, Whelan SP, Andrian UH von (2007)
Subcapsular sinus macrophages in lymph nodes clear lymph-
borne viruses and present them to antiviral B cells. Nature
450:110–114
Kaipainen A, Korhonen J, Mustonen T, Hinsbergh VW van, Fang GH,
Dumont D, Breitman M, Alitalo K (1995) Expression of the fms-
like tyrosine kinase 4 gene becomes restricted to lymphatic
endothelium during development. Proc Natl Acad Sci USA
92:3566–3570
138 Cell Tissue Res (2009) 335:109–141
Kaiserling E, Xiao JC, Adam A, Ruck P (1998) Der Lymphknotensi-
nus als Leitungssystem. Morphologische und immunhistochemi-
sche Befunde. In: Kaiserling E, Kröber SM, Ruck P (eds)
Lymphologica 1997 Year Book. Kagerer Kommunikation, Bonn,
pp 37–43
Kaldjian EP, Gretz JE, Anderson AO, Shi Y, Shaw S (2001) Spatial
and molecular organization of lymph node T cell cortex: a
labyrinthine cavity bounded by an epithelium-like monolayer of
fibroblastic reticular cells anchored to basement membrane-like
extracellular matrix. Int Immunol 13:1243–1253
Kartenbeck J, Schwechheimer K, Moll R, Franke WW (1984)
Attachment of vimentin filaments to desmosomal plaques in
human meningiomal cells and arachnoidal tissue. J Cell Biol
98:1072–1081
Kawachi K, Nakatani Y, Inayama Y, Kawano N, Toda N, Misugi K
(2002) Interdigitating dendritic cell sarcoma of the spleen: report
of a case with a review of the literature. Am J Surg Pathol
26:530–537
Kawaguchi J, Azuma Y, Hoshi K, Kii I, Takeshita S, Ohta T, Ozawa
H, Takeichi M, Chisaka O, Kudo A (2001a) Targeted disruption
of cadherin-11 leads to a reduction in bone density in calvaria
and long bone metaphyses. J Bone Miner Res 16:1265–1271
Kawaguchi J, Kii I, Sugiyama Y, Takeshita S, Kudo A (2001b) The
transition of cadherin expression in osteoblast differentiation
from mesenchymal cells: consistent expression of cadherin-11 in
osteoblast lineage. J Bone Miner Res 16:260–269
Kevil CG, Payne DK, Mire E, Alexander JS (1998) Vascular per-
meability factor/vascular endothelial cell growth factor-mediated
permeability occurs through disorganization of endothelial
junctional proteins. J Biol Chem 273:15099–15103
Koch PJ, Walsh MJ, Schmelz M, Goldschmidt MD, Zimbelmann R,
Franke WW (1990) Identification of desmoglein, a constitutive
desmosomal glycoprotein, as a member of the cadherin family of
cell adhesion molecules. Eur J Cell Biol 53:1–12
Koeser J, Troyanovsky SM, Grund C, Franke WW (2003) De novo
formation of desmosomes in cultured cells upon transfection of
genes encoding specific desmosomal components. Exp Cell Res
285:114–130
Kowalczyk AP, Navarro P, Dejana E, Bornslaeger EA, Green KJ,
Kopp DS, Borgwardt JE (1998) VE-cadherin and desmoplakin
are assembled into dermal microvascular endothelial intercellular
junctions: a pivotal role for plakoglobin in the recruitment of
desmoplakin to intercellular junctions. J Cell Sci 111:3045–3057
Kramer RH, Rosen SD, McDonald KA (1988) Basement-membrane
components associated with the extracellular matrix of the lymph
node. Cell Tissue Res 252:367–375
Krenács T, Rosendaal M (1995) Immunohistological detection of gap
junctions in human lymphoid tissue: connexin43 in follicular
dendritic and lymphoendothelial cells. J Histochem Cytochem
43:1125–1137
Krokowski M, Merz H, Thorns C, Bernd HW, Schade U, Le TA,
Diebold J, Feller AC (2008) Sarcoma of follicular dendritic cells
with features of sinus lining cells—a new subtype of reticulum
cell sarcoma? Virchows Arch 452:565–570
Kubo H, Alitalo K (2003) The bloody fate of endothelial stem cells.
Genes Dev 17:322–329
Lambeng N, Wallez Y, Rampon C, Cand F, Christe G, Gulino-Debrac
D, Vilgrain I, Huber P (2005) Vascular endothelial-cadherin
tyrosine phosphorylation in angiogenic and quiescent adult
tissues. Circ Res 96:384–391
Lampugnani MG, Dejana E (1997) Interendothelial junctions: structure,
signalling and functional roles. Curr Opin Cell Biol 9:674–682
Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O,
Geiger B, Dejana E (1995) The molecular organization of
endothelial cell to cell junctions: differential association of
plakoglobin, beta-catenin, and alpha-catenin with vascular
endothelial cadherin (VE-cadherin). J Cell Biol 129:203–217
Lampugnani MG, Zanetti A, Breviario F, Balconi G, Orsenigo F,
Corada M, Spagnuolo R, Betson M, Braga V, Dejana E (2002)
VE-cadherin regulates endothelial actin activating Rac and
increasing membrane association of Tiam. Mol Biol Cell
13:1175–1189
Lucioni M, Boveri E, Rosso R, Benazzo M, Necchi V, Danova M,
Incardona P, Franco C, Viglio A, Riboni R, Lazzarino M,
Magrini U, Canevari A, Paulli M (2003) Lymph node reticulum
cell neoplasm with progression into cytokeratin-positive intersti-
tial reticulum cell (CIRC) sarcoma: a case study. Histopathology
43:583–591
Luo Y, Radice GL (2005) N-cadherin acts upstream of VE-cadherin in
controlling vascular morphogenesis. J Cell Biol 169:29–34
Luo Y, Kostetskii I, Radice GL (2005) N-cadherin is not essential for
limb mesenchymal chondrogenesis. Dev Dyn 232:336–344
MacCalman CD, Furth EE, Omigbodun A, Bronner M, Coutifaris C,
Strauss JF III (1996) Regulated expression of cadherin-11 in
human epithelial cells: a role for cadherin-11 in trophoblast-
endometrium interactions? Dev Dyn 206:201–211
Mandell KJ, Parkos CA (2005) The JAM family of proteins. Adv
Drug Deliv Rev 57:857–867
Martel M, Sarli D, Colecchia M, Coppa J, Romito R, Schiavo M,
Mazzaferro V, Rosai J (2003) Fibroblastic reticular cell tumor of
the spleen: report of a case and review of the entity. Hum Pathol
34:954–957
Martinez-Pomares L, Gordon S (2007) Antigen presentation the
macrophage way. Cell 131:641–643
McCrea PD, Park JI (2007) Developmental functions of the P120-
catenin sub-family. Biochim Biophys Acta 1773:17–33
Mertens C, Kuhn C, Franke WW (1996) Plakophilins 2a and 2b:
constitutive proteins of dual location in the karyoplasm and the
desmosomal plaque. J Cell Biol 135:1009–1025
Mertens C, Kuhn C, Moll R, Schwetlick I, Franke WW (1999)
Desmosomal plakophilin 2 as a differentiation marker in normal
and malignant tissues. Differentiation 64:277–290
Mertens C, Hofmann I, Wang Z, Teichmann M, Sepehri CS, Schnölzer
M, Franke WW (2001) Nuclear particles containing RNA
polymerase III complexes associated with the junctional plaque
protein plakophilin 2. Proc Natl Acad Sci USA 98:7795–7800
Middel P, Patterson BW, Ophemert I van, Wacker HH, Parwaresch
MR, Radzun HJ, Zschunke F (2002) Cloning of a complemen-
tary DNA encoding the unique dendritic cell antigen Ki-M9. Cell
Tissue Res 307:347–355
Moe RE (1963) Fine structure of the reticulum and sinuses of lymph
nodes. Am J Anat 112:311–335
Moll R, Cowin P, Kapprell HP, Franke WW (1986) Desmosomal
proteins: new markers for identification and classification of
tumors. Lab Invest 54:4–25
Moll R, Holzhausen HJ, Mennel HD, Kuhn C, Baumann R, Taege C,
Franke WW (2006) The cardiac isoform of alpha-actin in
regenerating and atrophic skeletal muscle, myopathies and
rhabdomyomatous tumors: an immunohistochemical study using
monoclonal antibodies. Virchows Arch 449:175–191
Monda L, Warnke R, Rosai J (1986) A primary lymph node
malignancy with features suggestive of dendritic reticulum cell
differentiation. A report of 4 cases. Am J Pathol 122:562–572
Müller J, Tvrdík D, Dvorák R, Djaborkhel R, Mandys V, Bednár B,
Raska I, Lojda Z (2000) Expression of beta-catenins and
cadherins by follicular dendritic cells in human lymph nodes.
Acta Histochem 102:369–380
Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG,
Dejana E (1995) Catenin-dependent and -independent functions
of vascular endothelial cadherin. J Biol Chem 270:30965–30972
Cell Tissue Res (2009) 335:109–141 139
Navarro P, Ruco L, Dejana E (1998) Differential localization of VE-
and N-cadherins in human endothelial cells: VE-cadherin com-
petes with N-cadherin for junctional localization. J Cell Biol
140:1475–1484
Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M,
Tsukita S (2003) Size-selective loosening of the blood-brain
barrier in claudin-5-deficient mice. J Cell Biol 161:653–660
Nuber UA, Schäfer S, Schmidt A, Koch PJ, Franke WW (1995) The
widespread human desmocollin Dsc2 and tissue-specific patterns
of synthesis of various desmocollin subtypes. Eur J Cell Biol
66:69–74
Oxford EM, Musa H, Maass K, Coombs W, Taffet SM, Delmar M
(2007) Connexin43 remodeling caused by inhibition of plako-
philin-2 expression in cardiac cells. Circ Res 101:703–711
Perez-Ordonez B, Erlandson RA, Rosai J (1996) Follicular dendritic
cell tumor: report of 13 additional cases of a distinctive entity.
Am J Surg Pathol 20:944–955
Pfeiffer F, Kumar V, Butz S, Vestweber D, Imhof BA, Stein JV,
Engelhardt B (2008) Distinct molecular composition of blood
and lymphatic vascular endothelial cell junctions establishes
specific functional barriers within the peripheral lymph node. Eur
J Immunol 38:2142–2155
Phan TG, Grigorova I, Okada T, Cyster JG (2007) Subcapsular
encounter and complement-dependent transport of immune
complexes by lymph node B cells. Nat Immunol 8:992–1000
Pieperhoff S, Schumacher H, Franke WW (2008) The area composita
of adhering junctions connecting heart muscle cells of verte-
brates. V. The importance of plakophilin-2 demonstrated by small
interference RNA-mediated knockdown in cultured rat cardio-
myocytes. Eur J Cell Biol 87:399–411
Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, Skobe M
(2002) Molecular characterization of lymphatic endothelial cells.
Proc Natl Acad Sci USA 99:16069–16074
Prevo R, Banerji S, Ni J, Jackson DG (2004) Rapid plasma
membrane-endosomal trafficking of the lymph node sinus and
high endothelial venule scavenger receptor/homing receptor
stabilin-1 (FEEL-1/CLEVER-1). J Biol Chem 279:52580–52592
Rampon C, Prandini MH, Bouillot S, Pointu H, Tillet E, Frank R,
Vernet M, Huber P (2005) Protocadherin 12 (VE-cadherin 2) is
expressed in endothelial, trophoblast, and mesangial cells. Exp
Cell Res 302:48–60
Ratcliffe MJ, Smales C, Staddon JM (1999) Dephosphorylation of the
catenins p120 and p100 in endothelial cells in response to
inflammatory stimuli. Biochem J 338:471–478
Raviola E (1975) Lymph nodes. In: Bloom W, Fawcett DW (eds) A
textbook of histology. Saunders, Philadelphia, pp 471–486
Reilly JT, Nash JR, Mackie MJ, McVerry BA (1985) Distribution of
fibronectin and laminin in normal and pathological lymphoid
tissue. J Clin Pathol 38:849–854
Richardson SH, Starborg T, Lu Y, Humphries SM, Meadows RS,
Kadler KE (2007) Tendon development requires regulation of
cell condensation and cell shape via cadherin-11-mediated cell-
cell junctions. Mol Cell Biol 27:6218–6228
Roulet FC (1954) Differential diagnosis of reticulocytic proliferation
in the lymph nodes. Bibl Paediatr 58:706–721
Ruco LP, Pomponi D, Pigott R, Gearing AJ, Baiocchini A, Baroni CD
(1992) Expression and cell distribution of the intercellular
adhesion molecule, vascular cell adhesion molecule, endothelial
leukocyte adhesion molecule, and endothelial cell adhesion
molecule (CD31) in reactive human lymph nodes and in
Hodgkin’s disease. Am J Pathol 140:1337–1344
Sainte-Marie G, Peng FS (1986) Diffusion of a lymph-carried antigen
in the fiber network of the lymph node of the rat. Cell Tissue Res
245:481–486
Sakuma H, Kasajima T, Imai Y, Kojima M (1981) An electron
microscopic study on the reticuloendothelial cells in the lymph
nodes. Acta Pathol Jpn 31:449–472
Salomon D, Ayalon O, Patel-King R, Hynes RO, Geiger B (1992)
Extrajunctional distribution of N-cadherin in cultured human
endothelial cells. J Cell Sci 102:7–17
Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar
M (2005) Up-regulation of the lymphatic marker podoplanin, a
mucin-type transmembrane glycoprotein, in human squamous
cell carcinomas and germ cell tumors. Am J Pathol 166:913–
921
Schmelz M, Franke WW (1993) Complexus adhaerentes, a new group
of desmoplakin-containing junctions in endothelial cells: the
syndesmos connecting retothelial cells of lymph nodes. Eur J
Cell Biol 61:274–289
Schmelz M, Moll R, Franke WW (1990) A new type of intercellular
junction: desmosomal proteins in the extended junctions of certain
endothelial cells of the lymphatic systems. Cell Biol Int Rep 14:54
Schmelz M, Moll R, Kuhn C, Franke WW (1994) Complexus
adhaerentes, a new group of desmoplakin-containing junctions
in endothelial cells. II. Different types of lymphatic vessels.
Differentiation 57:97–117
Schmidt A, Jäger S (2005) Plakophilins—hard work in the desmo-
some, recreation in the nucleus? Eur J Cell Biol 84:189–204
Schuerfeld K, Lazzi S, De Santi MM, Gozzetti A, Leoncini L, Pileri
SA (2003) Cytokeratin-positive interstitial cell neoplasm: a case
report and classification issues. Histopathology 43:491–494
Schulze C, Firth JA (1993) Immunohistochemical localization of
adherens junction components in blood-brain barrier micro-
vessels of the rat. J Cell Sci 104:773–782
Shaw SK, Bamba PS, Perkins BN, Luscinskas FW (2001) Real-time
imaging of vascular endothelial-cadherin during leukocyte
transmigration across endothelium. J Immunol 167:2323–2330
Shibata T, Ochiai A, Gotoh M, Machinami R, Hirohashi S (1996) Simul-
taneous expression of cadherin-11 in signet-ring cell carcinoma and
stromal cells of diffuse-type gastric cancer. Cancer Lett 99:147–153
Sievers E (2009) Sinusendothel-/Virgultumzellen in normalen und
pathologisch veränderten menschlichen Lymphknoten. Morpho-
logische Befunde und immunhistochemische Markerprofile.
[Sinus endothelial/virgultar cells in normal and pathologically
altered human lymph nodes]. M.D. Thesis. Faculty of Medicine,
Philipps-University, Marburg, Germany
Simionescu N, Simionescu M (1988) Endothelial cell biology in
health and disease. Plenum, New York
Simonneau L, Thiery JP (1998) The mesenchymal cadherin-11 is
expressed in restricted sites during the ontogeny of the rat brain in
modes suggesting novel functions. Cell Adhes Commun 6:431–450
Simonneau L, Kitagawa M, Suzuki S, Thiery JP (1995) Cadherin 11
expression marks the mesenchymal phenotype: towards new
functions for cadherins? Cell Adhes Commun 3:115–130
Singer II, Tian M, Wickham LA, Lin J, Matheravidathu SS, Forrest
MJ, Mandala S, Quackenbush EJ (2005) Sphingosine-1-phosphate
agonists increase macrophage homing, lymphocyte contacts, and
endothelial junctional complex formation in murine lymph nodes.
J Immunol 175:7151–7161
Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, Pabst
R, Lutz MB, Sorokin L (2005) The conduit system transports
soluble antigens from the afferent lymph to resident dendritic cells
in the T cell area of the lymph node. Immunity 22:19–29
Sleeman JP, Krishnan J, Kirkin V, Baumann P (2001) Markers for the
lymphatic endothelium: in search of the holy grail? Microsc Res
Tech 55:61–69
Smedsrød B (2004) Clearance function of scavenger endothelial cells.
Comp Hepatol 3 (Suppl 1):S22
140 Cell Tissue Res (2009) 335:109–141
Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K (2002)
Lymphangiogenesis and cancer metastasis. Nat Rev Cancer
2:573–583
Sun X, Chang KC, Abruzzo LV, Lai R, Younes A, Jones D (2003)
Epidermal growth factor receptor expression in follicular den-
dritic cells: a shared feature of follicular dendritic cell sarcoma
and Castleman’s disease. Hum Pathol 34:835–840
Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi
M, Kawahara S, Honda G, Yamamoto S, Horiguchi S (1987)
Structure and expression of human thrombomodulin, a thrombin
receptor on endothelium acting as a cofactor for protein C
activation. EMBO J 6:1891–1897
Takai Y, Nakanishi H (2003) Nectin and afadin: novel organizers of
intercellular junctions. J Cell Sci 116:17–27
Telo’ P, Breviario F, Huber P, Panzeri C, Dejana E (1998)
Identification of a novel cadherin (vascular endothelial cad-
herin-2) located at intercellular junctions in endothelial cells. J
Biol Chem 273:17565–17572
Tew JG, Kosco MH, Burton GF, Szakal AK (1990) Follicular
dendritic cells as accessory cells. Immunol Rev 117:185–211
Tew JG, Wu J, Fakher M, Szakal AK, Qin D (2001) Follicular
dendritic cells: beyond the necessity of T-cell help. Trends
Immunol 22:361–367
Ueki T, Iwasawa K, Ishikawa H, Sawa Y (2008) Expression of
junctional adhesion molecules on the human lymphatic endothe-
lium. Microvasc Res 75:269–278
Ukropec JA, Hollinger MK, Salva SM, Woolkalis MJ (2000) SHP2
association with VE-cadherin complexes in human endothelial
cells is regulated by thrombin. J Biol Chem 275:5983–5986
Ushiki T, Ohtani O, Abe K (1995) Scanning electron microscopic
studies of reticular framework in the rat mesenteric lymph node.
Anat Rec 241:113–122
Valiron O, Chevrier V, Usson Y, Breviario F, Job D, Dejana E
(1996) Desmoplakin expression and organization at human
umbilical vein endothelial cell-to-cell junctions. J Cell Sci
109:2141–2149
Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P (1997) Targeted
null-mutation in the vascular endothelial-cadherin gene impairs
the organization of vascular-like structures in embryoid bodies.
Proc Natl Acad Sci USA 94:6273–6278
Wacker HH (1994) Sinus lining cells. Immune accessory cells of
lymph node sinuses. Veröff Pathol 143:1–217
Wacker HH, Frahm SO, Heidebrecht HJ, Parwaresch R (1997) Sinus-
lining cells of the lymph nodes recognized as a dendritic cell type by
the new monoclonal antibody Ki-M9. Am J Pathol 151:423–434
Wei SH, Rosen H, Matheu MP, Sanna MG, Wang SK, Jo E, Wong
CH, Parker I, Cahalan MD (2005) Sphingosine 1-phosphate type
1 receptor agonism inhibits transendothelial migration of medul-
lary T cells to lymphatic sinuses. Nat Immunol 6:1228–1235
Weiss LM, Berry GJ, Dorfman RF, Banks P, Kaiserling E, Curtis J,
Rosai J, Warnke RA (1990) Spindle cell neoplasms of lymph
nodes of probable reticulum cell lineage. True reticulum cell
sarcoma? Am J Surg Pathol 14:405–414
Weiss SW, Gnepp DR, Bratthauer GL (1989) Palisaded myofibro-
blastoma. A benign mesenchymal tumor of lymph node. Am J
Surg Pathol 13:341–346
Welsch U, Schwertfirm S, Skirnisson K, Schumacher U (1997)
Histological, histochemical, and fine structural observations on
the lymph node of the common seal (Phoca vitulina) and the grey
seal (Halichoerus grypus). Anat Rec 247:225–242
Willard-Mack CL (2006) Normal structure, function, and histology of
lymph nodes. Toxicol Pathol 34:409–424
Wong EY, Morgan L, Smales C, Lang P, Gubby SE, Staddon JM
(2000) Vascular endothelial growth factor stimulates dephos-
phorylation of the catenins p120 and p100 in endothelial cells.
Biochem J 346(Pt 1):209–216
Wróbel T, Dziegiel P, Mazur G, Zabel M, Kuliczkowski K, Szuba A
(2005) LYVE-1 expression on high endothelial venules (HEVs)
of lymph nodes. Lymphology 38:107–110
Wuchter P, Boda-Heggemann J, Straub BK, Grund C, Kuhn C, Krause
U, Seckinger A, Peitsch WK, Spring H, Ho AD, Franke WW
(2007) Processus and recessus adhaerentes: giant adherens cell
junction systems connect and attract human mesenchymal stem
cells. Cell Tissue Res 328:499–514
Xiao K, Allison DF, Kottke MD, Summers SA, Sorescu GP, Faundez
V, Kowalczyk AP (2003) Mechanisms of VE-cadherin process-
ing and degradation in microvascular endothelial cells. J Biol
Chem 278:19199–19208
Xiao K, Garner J, Buckley KM, Vincent PA, Chiasson CM, Dejana E,
Faundez V, Kowalczyk AP (2005) p120-Catenin regulates clathrin-
dependent endocytosis of VE-cadherin. Mol Biol Cell 16:5141–5151
Yap AS, Crampton MS, Hardin J (2007) Making and breaking
contacts: the cellular biology of cadherin regulation. Curr Opin
Cell Biol 19:508–514
Yoshida T, Takaya K (1992) The enveloping of intercellular
collagenous fibrils by reticular cell processes in postnatal
development of rat lymph nodes. Arch Histol Cytol 55:351–359
Zhou X, Stuart A, Dettin LE, Rodriguez G, Hoel B, Gallicano GI
(2004) Desmoplakin is required for microvascular tube formation
in culture. J Cell Sci 117:3129–3140
Cell Tissue Res (2009) 335:109–141 141
